The Industry
The Russian clinical trial industry is experiencing rapid growth as global and local pharmaceutical companies are entering the market.
We maintain current list of all clinical trials approved by the FDA for the Russian Federation on our site for your reference.
|
|
Closed Studies
Abscess, Wound Infection, Diabetic Foot, Ulcer: Comparison of Sequential IV/PO Moxifloxacin With IV Piperacillin/Tazobactam Followed by PO Amoxicillin/Clavulanic Acid in Patients With a Complicated Skin and Skin Structure Infection (NCT00402727)
Acne Vulgaris: Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa (NCT00280657)
Acromegaly: Safety and Efficacy of Pasireotide Long Acting Release (LAR) vs. Octreotide LAR in Patients With Active Acromegaly (NCT00600886)
Acute Coronary Disease, Angina Unstable: Clopidogrel Optimal Loading Dose Usage to Reduce Recurrent EveNTs/Optimal Antiplatelet Strategy for InterventionS (NCT00335452)
Acute Coronary Syndrome: A Comparison of AZD6140 and Clopidogrel in Patients With Acute Coronary Syndrome (NCT00391872)
Acute Coronary Syndrome: Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome (NCT00997750)
Acute Coronary Syndrome: FRANCIS-ACS Trial: A Study of the Safety and Efficacy of A 002 in Subjects With Acute Coronary Syndromes (NCT00743925)
Acute Coronary Syndrome: Intravenous Aspirin in the Intravenous Treatment of Acute Coronary Syndrome (NCT00910065)
Acute Coronary Syndrome: Safety and Efficacy of TAK-442 in Subjects With Acute Coronary Syndromes (NCT00677053)
Acute Coronary Syndrome: Safety Study of Apixaban in Recent Acute Coronary Syndrome (NCT00313300)
Acute Coronary Syndromes: Clopidogrel as Adjunctive Reperfusion Therapy - Thrombolysis in Myocardial Infarction (NCT00714961)
Acute Decompensated Heart Failure: Study to Assess Hemodynamic Effects, Safety and Tolerability of Chimeric Natriuretic Peptide (CD-NP) in Patients With Stabilized Acute Heart Failure (AHF) (NCT00699712)
Acute Decompensated Heart Failure, Renal Dysfunction: Safety and Efficacy Study to Evaluate the Effect of SLV320 on Renal Function in Patients With Worsening Heart Failure (NCT00744341)
Acute Gout: Targeted Dose Finding of Canakinumab (ACZ885) for Management of Acute Flare in Refractory or Contraindicated Gout Patients (NCT00798369)
Adenocarcinoma, Neoplasms: Study Evaluating Biomarkers in Relapsed/Refractory Pediatric Solid Tumors (NCT00106353)
Adenomatous Polyps: Chemoprevention of Colorectal Adenomas (NCT00486512)
Albuminuria: Irbesartan Versus Placebo in Combination With Ramipril for Treatment of Albuminuria (NCT00095290)
Alcohol Dependence: Safety of Nalmefene in Patients With Alcohol Dependence (NCT00811941)
Alzheimers Disease: A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimers Disease (NCT00224497)
Alzheimers Disease: Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimers Disease (NCT00377715)
Alzheimers Disease: Proof of Concept Study of Cognitive Improvement in Patients With Alzheimers Disease (NCT00501111)
Alzheimers Disease: Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimers Disease (NCT00428090)
Alzheimers Disease: SB-742457 And Donepezil In Alzheimers Disease (NCT00348192)
Alzheimers Disease, Dementia, Alzheimer Type: Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimers Disease (NCT00099242)
Alzheimers Disease, Mild-to-Moderate: Study Of Rosiglitazone XR In Subjects With Mild-to-Moderate Alzheimers (NCT00550420)
Anemia: (ACORD Study) - A Study of NeoRecormon (Epoetin Beta) in Patients With Early Diabetic Nephropathy (NCT00354341)
Anemia: A Study of Intravenous Mircera in Dialysis Patients With Chronic Renal Disease and Anemia. (NCT00576303)
Anemia: A Study of Intravenous or Subcutaneous Mircera in Chronic Kidney Disease Patients With Renal Anemia. (NCT00090753)
Anemia: A Study of Mircera for the Treatment of Anemia in Dialysis Patients (NCT00077597)
Anemia: A Study of Subcutaneous Mircera for the Treatment of Anemia in Pre-Dialysis Patients. (NCT00576628)
Anemia: A Study of Subcutaneous Mircera Once Monthly in the Treatment of Anemia in Patients With Chronic Kidney Disease Not on Dialysis. (NCT00559273)
Anemia: A Study of the Quality of Life and Treatment Response to Once Weekly NeoRecormon (Epoetin Beta) Treatment in Anemic Patients With Solid and Lymphoid Malignancies. (NCT00776425)
Anemia: A Study of Treatment With NeoRecormon (Epoetin Beta) in Patients With Chronic Renal Anemia (NCT00321919)
Anemia: Study of the Efficacy of Two Doses of Ferrlecit in the Treatment of Iron Deficiency in Pediatric Hemodialysis Patients (NCT00223964)
Anemia, Cancer: Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer (NCT00091858)
Anemia, Chronic Renal Failure: Safety Study of Hematide to Correct Anemia in Hemodialysis Patients (NCT00680043)
Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients (NCT00701714)
Antifungal Prophylaxis: Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) (NCT00289991)
Anxiety Disorder: A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder (NCT00122837)
Anxiety Disorder, Head Injury, Mood Disorder, Schizophrenia, Seizures: Neuropsychological Evaluation of Psychiatric and Neurological Patients (NCT00001192)
Anxiety Disorders: An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder (NCT00266747)
Anxiety Disorders: Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder (NCT00389064)
Anxiety Disorders: Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder (NCT00397098)
Anxiety Disorders: Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients. (NCT00314210)
Arrhythmias: Study Evaluating GAP-486 in Non-Sustained Ventricular Tachycardia (NCT00124891)
Arterial Hypertension: Analysis of Antihypertensive Treatment Efficacy (NCT00767247)
Arteriosclerosis: Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) (NCT00050817)
Ascites, Liver Cirrhosis: Cirrhotic Ascites Treatment With Satavaptan in Patients With Ascites Due to Cirrhosis of the Liver (CATS) (NCT00358878)
Ascites, Liver Cirrhosis: Satavaptan for the Prevention of Ascites Recurrence in Patients With Ascites Due to Cirrhosis of the Liver (NCT00366795)
Asthma: A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 HFA Versus Fluticasone Propionate 100 HFA In Children With Asthma (NCT00441441)
Asthma: A Comparative Study of Inhaled Ciclesonide Versus Placebo in Children With Asthma (6-11 y) (BY9010/M1-209) (NCT00384189)
Asthma: A Dose Ranging Trial of 4 Doses of Indacaterol Delivered Via Twisthaler in Adult and Adolescent Patients With Persistent Asthma (NCT00545272)
Asthma: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Low-Dose ICS Therapy. (NCT00603278)
Asthma: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Moderate-Dose ICS Therapy. (NCT00603746)
Asthma: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Asthma Uncontrolled on Non-steroidal Therapy. (NCT00603382)
Asthma: A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma. (NCT00398645)
Asthma: Efficacy and Safety of Ciclesonide (CIC) Administered Twice Daily in Pediatric Patients With Asthma. (NCT00392288)
Asthma: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma (NCT00044811)
Asthma: Efficacy and Safety of Fexofenadine in Mild to Moderate Persistent Asthma (NCT00044824)
Asthma: Efficacy and Safety of Oral Roflumilast Taken With Low Dose Inhaled Corticosteroids in Patients With Asthma (12 to 70 y) (BY217/M2-013) (NCT00163527)
Asthma: Efficacy and Safety of Tiotropium and Salmeterol in Moderate Persistent Asthma Patients Homozygous for B16-Arg/Arg (NCT00350207)
Asthma: Efficacy of Ciclesonide vs Placebo Administered as Once Daily or Twice Daily in Patients Not Treated With Inhaled Corticosteroid. (NCT00174720)
Asthma: Evaluation of Safety and Efficacy of Symbicort pMDI, With or Without Spacer, in Children (6-11 Years) With Asthma (NCT00536913)
Asthma: Local Phase 4 Pan-European SMART Study (NCT00463866)
Asthma: Repeat Doses Of A New Medication (GW642444) In Asthmatic Patients (NCT00347139)
Asthma: Seretide Versus Flixotide In Asthmatic Children Not Controlled By Inhaled Corticosteroids (NCT00353873)
Asthma: Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients (NCT00358488)
Asthma: The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023) (NCT00076076)
Asthma, Bronchial: Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma (NCT00189787)
Asthma, Bronchial: Efficacy and Tolerability of Beclomethasone Plus Salbutamol in HFA pMDI Fixed Combination vs Beclomethasone Plus Salbutamol in CFC pMDI Fixed Combination in a 12-Week Treatment Period of Adult Patients With Uncontrolled Asthma (NCT00528723)
Asthma, Bronchial: Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids and Long Acting B2 Agonists in Moderate to Severe Persistent Asthma (NCT00189722)
Asthma, Mild to Moderate Persistent : OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma (NCT00890877)
Asthma, Persistent : Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma. (NCT00600171)
Atrial Fibrillation: Evaluation of Weekly Subcutaneous Biotinylated Idraparinux Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation (NCT00580216)
Atrial Fibrillation: Efficacy and Safety of Dronedarone Versus Amiodarone for the Maintenance of Sinus Rhythm in Patients With Atrial Fibrillation (NCT00489736)
Atrial Fibrillation: Efficacy and Safety Evaluation of Azimilide or Sotalol vs Placebo for Treatment of Patients With Atrial Fibrillation. (NCT00035451)
Atrial Fibrillation: Explorative Study of AZD1305 in Atrial Fibrillation Patients (NCT00643448)
Atrial Fibrillation: RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed RE-LY Trial (NCT00808067)
Atrial Fibrillation: Study of K201 Injection on Restoration of Sinus Rhythm in Subjects Who Are in Atrial Fibrillation (NCT00626652)
Atrial Fibrillation: Vernakalant (Oral) Prevention of Atrial Fibrillation Recurrence Post-Conversion Study (NCT00526136)
Atrial Fibrillation, Atrial Flutter: A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (NCT00174785)
Atrial Fibrillation, Atrial Flutter: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female Subjects (NCT00126022)
Atrial Fibrillation, Atrial Flutter: Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male Subjects (NCT00126061)
Atrial Fibrillation, Atrial Flutter: Placebo Controlled Double-Blind Dose Ranging Study of the Efficacy and Safety of SSR149744C 50, 100, 200 or 300 mg OD With Amiodarone as Calibrator for the Maintenance of Sinus Rhythm in Patients With Recent Atrial Fibrillation/Flutter (NCT00233441)
Atrial Fibrillation, Cerebrovascular Accident: Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate (NCT00262600)
Atrial Fibrillation, Stroke: Randomized, Double-Blind Study Comparing Once Daily Oral Rivaroxaban With Adjusted-Dose Oral Warfarin for the Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation (NCT00403767)
Atrial Fibrillation, Thromboembolism: A Study to Assess the Safety of a Potential New Drug in Comparison to the Standard Practice of Dosing With Warfarin for Non-Valvular Atrial Fibrillation (NCT00504556)
Atrial Fibrillation, Vascular Risk: Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W) (NCT00243178)
Attention Deficit Disorder With Hyperactivity: Efficacy, Tolerability, and Safety of Once-Daily Atomoxetine Hydrochloride Versus Placebo in Russian Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (NCT00386581)
Bacterial Infections: Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections (NCT00423657)
Bacterial Infections: Comparative Study of Ceftaroline vs. Vancomycin Plus Aztreonam in Adult Subjects With Complicated Skin Infections (NCT00424190)
Bacterial Infections, Diabetic Foot, Osteomyelitis: Study Evaluating the Safety and Efficacy of a Once-daily Dose of Tigecycline vs Ertapenem in Diabetic Foot Infections With a Substudy in Patients With Diabetic Foot Infections Complicated by Osteomyelitis. (NCT00366249)
Bacterial Pneumonia: Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia (NCT00621504)
Bacterial Pneumonia: Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia (NCT00509106)
Bacterial Pneumonia: Study Evaluating Safety and Efficacy of Tigecycline Versus Imipenem/Cilastatin Subjects With Hospital Acquired Pneumonia (NCT00707239)
B-cell Lymphocytic Leukemia: Fludara Plus Alemtuzumab (Campath, MabCampath) vs Fludara Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients (NCT00086580)
Benign Prostatic Hyperplasia: A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding. (NCT00379067)
Benign Prostatic Hyperplasia: Benign Prostatic Hyperplasia Trial With AVODART And Tamsulosin Combination Treatment (NCT00090103)
Biliary Tract Cancer: XL119 Versus 5-Fluorouracil (5-FU) Plus Leucovorin (LV) in Subjects With Advanced Biliary Tumors (NCT00090025)
Bipolar Disorder: A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania (NCT00261443)
Bipolar Disorder: Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania (NCT00190892)
Bipolar Disorder: Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder (NCT00094549)
Bipolar Disorder: Open Label Extension Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar I Disorder (NCT00139594)
Bipolar Disorder: Quetiapine Fumarate Bipolar Maintenance Monotherapy (NCT00314184)
Bipolar Disorder: Study of Aripiprazole in Patients With Acute Bipolar Mania (NCT00097266)
Bipolar Disorder: Study of Aripiprazole in Patients With Bipolar I Disorder (NCT00257972)
Bipolar Disorder: Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00099229)
Bipolar Disorder: Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder (NCT00107926)
Bipolar Disorder, Bipolar Depression, Depression: Seroquel in Bipolar Depression Versus Lithium (NCT00206141)
Bipolar I Disorder: Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder (NCT00107731)
Bipolar Mania, Bipolar Disorder: Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed) (NCT00280566)
Birch Pollen-Related Rhinoconjunctivitis, Rhinitis, Allergic, Seasonal: Study of rBet v1 Tablets (NCT00901914)
Bladder Cancer, Transitional Cell Carcinoma, Metastasis: First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ?± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy (NCT00389155)
Bladder, Neurogenic: PK/PD, Long-term Safety and Efficacy of Tamsulosin Treatment in Children With Neurogenic Bladder (NCT00340704)
Bladder, Neurogenic: Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder (NCT00796614)
Blepharospasm, Hemifacial Spasm, Cervical Dystonia, Spasmodic Torticollis, Cerebral Palsy, Muscle Spasticity, Cerebrovascular Accident, Equinus Deformity, Facial Hyperdynamic Lines: Post Marketing Surveillance Study of Dysport (NCT00210431)
Bone Metastases in Men With Hormone-Refractory Prostate Cancer: Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Men With Hormone-refractory Prostate Cancer (NCT00321620)
Bone Metastases in Subjects With Advanced Breast Cancer: A Study Comparing Denosumab vs. Zoledronic Acid for the Treatment of Bone Metastases in Breast Cancer Subjects. (NCT00321464)
Bone Metastases in Subjects With Advanced Cancer or Multiple Myeloma: Double-blind Study of Denosumab Compared With Zoledronic Acid in the Treatment of Bone Metastases in Subjects With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma (NCT00330759)
Breast Cancer: A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. (NCT00391092)
Breast Cancer: 5-Fluorouracil Combined With CoFactor (5-10 Methylenetetrahydrofolate) in Treating Advanced Breast Cancer Patients (NCT00434369)
Breast Cancer: A Study of Avastin (Bevacizumab) Plus Taxane-Based Therapy in Patients With Locally Recurrent or Metastatic Breast Cancer. (NCT00448591)
Breast Cancer: A Study of Pemetrexed and Cyclophosphamide Given Every 21 Days in Advanced Breast Cancer Patients (NCT00190671)
Breast Cancer: A Study of Pertuzumab in Combination With Herceptin in Patients With HER2 Positive Breast Cancer. (NCT00545688)
Breast Cancer: A Study to Assess Xeloda (Capecitabine) in Patients With Locally Advanced or Metastatic Breast Cancer (NCT00077857)
Breast Cancer: A Study to Evaluate the Efficacy and Safety of Herceptin (Trastuzumab) in Combination With an Aromatase Inhibitor in Patients With Metastatic Breast Cancer (NCT00022672)
Breast Cancer: BEATRICE Study: A Study of Avastin (Bevacizumab) Adjuvant Therapy in Triple Negative Breast Cancer. (NCT00528567)
Breast Cancer: Capecitabine (XELODA) With Or Without Lapatinib(GW572016)For Women With Refractory Advanced or Metastatic Breast Cancer (NCT00078572)
Breast Cancer: Chemotherapy Plus Surgery in Treating Women With Breast Cancer (NCT00003013)
Breast Cancer: Combination Chemotherapy for Metastatic Breast Cancer (NCT00191815)
Breast Cancer: Comparison of Fulvestrant (FASLODEXTM) 250 mg and 500mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. (NCT00099437)
Breast Cancer: Docetaxel in Breast Cancer (NCT00312208)
Breast Cancer: E7389 Versus Treatment of Physicians Choice in Patients With Locally Recurrent or Metastatic Breast Cancer (NCT00388726)
Breast Cancer: Epothilone (Ixabepilone) Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer (NCT00082433)
Breast Cancer: Evaluation of Safety and Efficacy of TOCOSOL(R) Paclitaxel as Initial Treatment for Metastatic Breast Cancer (NCT00096668)
Breast Cancer: Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer (NCT00002777)
Breast Cancer: Lapatinib Combined With Paclitaxel For Patients With First-Line ErbB2-Amplified Metastatic Breast Cancer (NCT00356811)
Breast Cancer: Preoperative Treatment of Breast Cancer With Two Different Sequential Treatment Regimens (NCT00149214)
Breast Cancer: Quality Of Life While Receiving Faslodex (NCT00643513)
Breast Cancer: Study to Assess Effectiveness of Giving Combination of Standard Chemotherapy Drugs Versus Combination of Standard Chemotherapy and New Drug Ixabepilone When Given Before Surgical Removal of Early Stage Breast Cancer (NCT00455533)
Breast Cancer: Trastuzumab in Treating Women With Primary Breast Cancer (NCT00045032)
Breast Cancer: Trial of Myocet in Metastatic Breast Cancer (NCT00294996)
Breast Cancer: Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer (NCT00374322)
Breast Cancer, Advanced: Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-menopausal Women (NCT00322348)
Breast Cancer, ErbB2+, Early: Neo ALTTO (Neoadjuvant Lapatinib and/or Trastuzumab Treatment Optimisation) Study (NCT00553358)
Breast Cancer, ErbB2+, Her2+, Metastatic : Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 (NCT00281658)
Breast Cancer, Metastasis: A Trial Comparing the Efficacy and Tolerability of Faslodex With Nolvadex in Postmenopausal Women With Advanced Breast Cancer (NCT00241449)
Breast Cancer, Metastatic : A Study to Evaluate the Safety and Efficacy of Bevacizumab in Combination With Chemotherapy in Previously Treated Metastatic Breast Cancer (RIBBON 2) (NCT00281697)
Breast Cancer, Metastatic : An Open-Label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Capecitabine (NCT00165880)
Breast Cancer, Metastatic : E7389 Versus Capecitabine in Patients With Locally Advanced or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes (NCT00337103)
Breast Cancer, Metastatic : Paclitaxel With / Without GW572016 (Lapatinib) As First Line Therapy For Women With Advanced Or Metastatic Breast Cancer (NCT00075270)
Breast Cancer, Metastatic : Pazopanib Plus Lapatinib Compared To Lapatinib Alone In Subjects With Advanced Or Metastatic Breast Cancer (NCT00347919)
Breast Cancer, Metastatic : Study of TAS-108 in Postmenopausal Patients With Locally Advanced Breast Carcinoma Following Standard First or Second Line Endocrine Therapy (NCT00687557)
Breast Cancer, Metastatic, Advanced: Study Comparing GW572016 And Letrozole Versus Letrozole In Subjects With Advanced Or Metastatic Breast Cancer (NCT00073528)
Breast Cancer, Metastatic, Recurrent : Pharmacokinetic Study of Tesmilifene (YMB1002) Plus Epirubicin and Cyclophosphamide in Metastatic Breast Cancer (NCT00364754)
Breast Cancer, Neoplasm Metastasis: Pemetrexed and Carboplatin in Locally Advanced or Metastatic Breast Cancer (NCT00072865)
Breast Carcinoma: Phase II Study of AS1402 Combined With Letrozole to Treat Breast Cancer (NCT00770354)
Breast Neoplasm: Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women (NCT00107016)
Breast Neoplasms: A Study Of Sunitinib In Combination With Capecitabine Compared With Capecitabine In Patients With Breast Cancer (NCT00435409)
Breast Neoplasms: Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer (NCT00021255)
Breast Neoplasms: Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer (NCT00038467)
Breast Neoplasms,: Study Evaluating HKI-272 in Subjects With Advanced Breast Cancer (NCT00300781)
Breast Neoplasms, Breast Cancer: Safety and Efficacy Study of the Trifunctional Antibody Ertumaxomab to Treat Patients With Advanced or Metastatic Breast Cancer (NCT00351858)
Breast Neoplasms, Neoplasm Metastasis: Study Evaluating SKI-606 in Subjects With Breast Cancer (NCT00319254)
Breast Neoplasms, Neoplasms, Hormone-Dependent: Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer (NCT00044291)
Breast Neoplasms, Neoplasms, Hormone-Dependent: The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer (NCT00097344)
Breast Neoplasms, Neoplasms, Hormone-Dependent: Treatment and Survival Continuation Study of Atamestane Plus Toremifene vs Letrozole in Advanced Breast Cancer (NCT00267553)
Bronchitis, Chronic: A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis (NCT00644449)
Burn, Trauma, Varicose Ulcer: Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor Sites (NCT00426972)
Cancer Pain, Bowel Dysfunction: Study 767905/008 Extension Study: Alvimopan for Treatment of Opioid-Induced Bowel Dysfunction in Cancer Pain Subjects (NCT00135577)
Cancer, Venous Thromboembolism: CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) (NCT00219973)
Cardiovascular Diseases: Comprehensive Rimonabant Evaluation Study of Cardiovascular ENDpoints and Outcomes (NCT00263042)
Cardiovascular Diseases: Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo. (NCT00153101)
Cardiovascular Diseases: JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular Events (NCT00239681)
Cardiovascular Risk Factors: European Study of Cardiovascular Risk (NCT00882336)
Cerebral Stroke: Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke (NCT00061022)
Cerebrovascular Accident: PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes (NCT00153062)
Cervical Dystonia: Open-label Extension Study of Botulinum Type A Toxin (Dysport®) for the Treatment of Cervical Dystonia (NCT00288509)
Cervical Dystonia: Randomized, Placebo-Controlled Study of Botulinum Type A Toxin (Dysport®) for the Treatment of Cervical Dystonia (NCT00257660)
Cervical Dystonia: Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia (NCT00564681)
Chemotherapy Induced Nausea and Vomiting: A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. (NCT00601172)
Chemotherapy Induced Nausea and Vomiting: Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting (NCT00366834)
Chemotherapy Induced Nausea and Vomiting: Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy (NCT00104403)
Chemotherapy Induced Neutropenia: Neugranin in Breast Cancer Patients Receiving Doxorubicin/Docetaxe (NCT00837265)
Chronic Heart Failure: Ferinject® Assessment in Patients With IRon Deficiency and Chronic Heart Failure (FAIR-HF) (NCT00520780)
Chronic Insomnia: Long-Term Efficacy and Safety of Ramelteon in Adults With Chronic Insomnia. (NCT00247390)
Chronic Kidney Disease: Post-authorization Safety Study in CKD Subjects Receiving HX575 i.v. (NCT00632125)
Chronic Kidney Disease: Study of Phosphate Levels in Patients With Chronic Kidney Disease (NCT00824460)
Chronic Kidney Disease Stage 5, Left Ventricular Hypertrophy: The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With CKD Stage 5 (NCT00616902)
Chronic Kidney Disease, Dialysis, Hyperphosphatemia, Dyslipidemia: A Study of MCI-196 in Chronic Kidney Disease Subjects on Dialysis With Hyperphosphatemia and Dyslipidaemia (NCT00542386)
Chronic Kidney Disease, End Stage Renal Disease, Coronary Artery Calcification, Vascular Calcification, Calcification, Cardiovascular Disease, Chronic Renal Failure, Hyperparathyroidism, Kidney Disease, Nephrology, Secondary Hyperparathyroidism: ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis (NCT00379899)
Chronic Kidney Disease, Left Ventricular Hypertrophy: The PRIMO Study-Paricalcitol Capsules Benefits in Renal Failure Induced Cardiac Morbidity in Chronic Kidney Disease Stage 3/4 (NCT00497146)
Chronic Liver Disease: Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures (NCT00678587)
Chronic Low Back Pain: A Study for Patient With Chronic Low Back Pain (NCT00767806)
Chronic Lymphocytic Leukemia: Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia (NCT00004218)
Chronic Lymphocytic Leukemia: FCR Versus FC Alone in the Treatment of Chronic Lymphocytic Leukemia (CLL) (NCT00090051)
Chronic Lymphocytic Leukemia: Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT00391066)
Chronic Myelogenous Leukemia: Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML (NCT00574873)
Chronic Myeloid Leukemia: A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML (NCT00481247)
Chronic Myeloid Leukemia: Chronic Myelogenous Leukemia (CML) - Follow on: Study of BMS-354825 in Subjects With CML (NCT00123474)
Chronic Myeloid Leukemia: Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia (NCT00302016)
Chronic Myeloid Leukemia: Study of Dasatinib in Patients With Chronic Phase CML and a Suboptimal Response to Imatinib (NCT00320190)
Chronic Myeloid Leukemia, Accelerated Phase, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive: Advanced Chronic Myelogenous Leukemia (CML) - Follow On: Study of BMS-354825 in Subjects With CML (NCT00123487)
Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia: Study of Dasatinib in Imatinib Resistant or Intolerant Subjects With Chronic or Advanced Phase CML or Philadelphia Chromosome Positive ALL (NCT00349518)
Chronic Myeloid Leukemia, Philadelphia-Positive Myeloid Leukemia: Dasatinib (BMS-354835) Versus Imatinib Mesylate in Subjects With Chronic Myeloid Leukemia (NCT00103844)
Chronic Obstructive Pulmonary Disease: A Study to Compare the Lung Effect of Indacaterol and Tiotropium in Chronic Obstructive Pulmonary Disease (COPD) (NCT00900731)
Chronic Obstructive Pulmonary Disease: An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. (NCT00528996)
Chronic Obstructive Pulmonary Disease: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease. Ratio-Study. (BY217/M2-112) (NCT00430729)
Chronic Obstructive Pulmonary Disease: Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD (NCT00530842)
Chronic Obstructive Pulmonary Disease: Efficacy, Safety and Tolerability of Once-daily (o.d.) Indacaterol in Chronic Obstructive Pulmonary Disease (COPD) Using Formoterol Twice Daily (b.i.d.) as Active Control (NCT00393458)
Chronic Obstructive Pulmonary Disease: Evaluation of Efficacy and Safety of Formoterol in Patients With COPD Compared With Placebo in Patients in Japan, EU (NCT00628862)
Chronic Obstructive Pulmonary Disease: Evaluation of the Long- Term Effects of Spiriva on Lung Function in COPD Patients (NCT00144339)
Chronic Obstructive Pulmonary Disease: Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD) (NCT00400153)
Chronic Obstructive Pulmonary Disease: RUSSE / Russian Spiriva Safety and Efficacy Study (NCT00613574)
Chronic Obstructive Pulmonary Disease: Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II (NCT00796653)
Chronic Obstructive Pulmonary Disease: SERETIDE 50/500mcg Versus Tiotropium Bromide On Exacerbation Rates In Severe Chronic Obstructive Pulmonary Disease (NCT00361959)
Chronic Obstructive Pulmonary Disease: Tiotropium / Respimat One-Year Study (NCT00168831)
Chronic Obstructive Pulmonary Disease: Tiotropium / Respimat One-Year Study (NCT00168844)
Chronic Obstructive Pulmonary Disease: Tiotropium In Exercise (NCT00525512)
Chronic Obstructive Pulmonary Disease: Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. (NCT00563381)
Chronic Obstructive Pulmonary Disease : A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD). (NCT00606684)
Chronic Obstructive Pulmonary Disease : Chronic Obstructive Pulmonary Disease Endpoints Study (NCT00358358)
Chronic Obstructive Pulmonary Disease : Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124) (NCT00297102)
Chronic Obstructive Pulmonary Disease : Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) Using Salmeterol as Active Control (NCT00567996)
Chronic Obstructive Pulmonary Disease : Safety And Efficacy Of GSK233705 Plus Salmeterol Compared With 2 Active Comparators And Placebo In Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00422604)
Chronic Obstructive Pulmonary Disease : Study To Evaluate Safety And Tolerability Of GSK256066 In Chronic Obstructive Pulmonary Disease (COPD) Patients (NCT00549679)
Chronic Obstructive Pulmonary Disease : Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) (NCT00268216)
Chronic Pancreatitis, Pancreatectomy, Pancreatic Exocrine Insufficiency: A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and Pancreatectomy (NCT00414908)
Clotrimazole, Ovulen, Vulvovaginal Candidiasis: Comparative Efficacy of Ovule vs Tablet (NCT00755053)
Colorectal Adenocarcinoma: Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Colorectal Adenocarcinoma (NCT00034190)
Colorectal Adenoma: Prevention of Colorectal Sporadic Adenomatous Polyps (PRESAP) (NCT00141193)
Colorectal Cancer: A Study of Picoplatin in Colorectal Cancer (NCT00478946)
Colorectal Cancer: A Study of Xeloda (Capecitabine) as a First-Line Therapy in Patients With Metastatic Colorectal Cancer (NCT00069095)
Colorectal Cancer: A Study of Xeloda (Capecitabine) as Adjuvant Monotherapy in Patients With Colon Cancer. (NCT00502671)
Colorectal Cancer: A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon Cancer (NCT00069121)
Colorectal Cancer: First Line Metastatic Colorectal Cancer Therapy in Combination With FOLFOX (NCT00384176)
Colorectal Cancer: Fluorouracil and Leucovorin With or Without Irinotecan in Treating Patients With Metastatic Colorectal Cancer (NCT00004885)
Colorectal Cancer: Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer (NCT00457691)
Colorectal Cancer, EGFR-Expressing, Metastatic : Cetuximab Combined With Irinotecan in First-Line Therapy for Metastatic Colorectal Cancer (CRYSTAL) (NCT00154102)
Colorectal Cancer, Metastatic: Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone (NCT00339183)
Colorectal Cancer, Neoplasm Metastasis: Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) (NCT00125034)
Complicated Intra-Abdominal Infections: Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections (NCT00752219)
Congestive Heart Failure: EVEREST: Efficacy of Vasopressin Antagonism in hEart failuRE: Outcome Study With Tolvaptan (NCT00071331)
Congestive Heart Failure: Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve) (NCT00095238)
Congestive Heart Failure: Placebo Controlled, Randomized, Double-Blind, Multi-Center Study to Investigate the Efficacy and Tolerability of BAY 58-2667 (NCT00559650)
Congestive Heart Failure: Recombinant Human Relaxin for the Treatment of Decompensated CHF (NCT00406575)
Congestive Heart Failure: Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal Function (NCT00568009)
Congestive Heart Failure, Renal Insufficiency: Phase 2b Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency (NCT00709865)
Constipation, Bowel Dysfunction: Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication (NCT00101998)
Coronary Arteriosclerosis, Hypercholesterolemia: Comparative Atorvastatin Pleiotropic Effects (NCT00163202)
Coronary Atherosclerosis: CRESTOR Athero Imaging Head to Head IVUS Study (NCT00620542)
Coronary Atherosclerosis: Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction (NCT00123565)
Coronary Disease: RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome (NCT00621855)
Coronary Disease: Study of Otamixaban Versus Unfractionated Heparin (UFH) and Eptifibatide in Non-ST Elevation Acute Coronary Syndrome (NCT00317395)
Crohns Disease: A Phase III A Study to Assess the Safety of CDP870 for up to 84 Months Exposure (NCT00160524)
Crohns Disease: A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohns Disease (NCT00552344)
Crohns Disease: A Study to Evaluate the Efficacy and Safety of Certolizumab Pegol for Induction of Remission in Patients With Crohns Disease (NCT00552058)
Crohns Disease: Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohns Disease (NCT00295165)
Crohns Disease: Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohns Disease (NCT00206674)
Crohns Disease: Open-Label Trial of Leukine in Active Crohns Disease (NCT00206700)
Crohns Disease: Placebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohns Disease (NCT00528073)
Crohns Disease: Study to Assess the Safety of CDP870 for up to 84 Months Following Reintroduction of Treatment (NCT00160706)
Cutaneous T-Cell Lymphoma: A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphoma (NCT00106431)
Cysic Fibrosis: Safety and Efficacy of 12-wk Treatment With Two Doses of Tiotropium Respimat in Cystic Fibrosis (NCT00737100)
Cystic Fibrosis: A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis (NCT00757848)
Deep Vein Thrombosis, Pulmonary Embolism: Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (NCT00423319)
Deep Vein Thrombosis, Pulmonary Embolism: Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery (NCT00371683)
Deep Venous Thrombosis: Bioequipotency Study of SSR126517E and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs (EQUINOX) (NCT00311090)
Depression: Nexalin Therapy for the Treatment of Depressive Symptoms (NCT00774813)
Depressive Disorder: An Eight-Week Study Evaluating the Efficacy of a 100mg Dose of Saredutant Once Daily, in Elderly Patients With Major Depressive Disorder (NCT00415142)
Depressive Disorder: An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder (NCT00361491)
Depressive Disorder, Major: A Comparison of Sertraline-Reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression. (NCT00636246)
Depressive Disorder, Major: A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD) (NCT00275197)
Depressive Disorder, Major: An Eight-Week Study of Saredutant and Paroxetine as Combination Treatment for Major Depressive Disorder (NCT00629551)
Depressive Disorder, Major: Duloxetine Versus Placebo in the Prevention of Recurrence of Major Depressive Disorder (NCT00105989)
Depressive Disorder, Major: Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive Disorder (NCT00143091)
Depressive Disorder, Major Depression: A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder (NCT00345098)
Diabetes Mellitus, Type 1: Comparison of NN1250 Plus Insulin Aspart With Insulin Glargine Plus Insulin Aspart in Type 1 Diabetes (NCT00982228)
Diabetes Mellitus, Type 1: Comparison of NN5401 Plus Insulin Aspart With Insulin Detemir Plus Insulin Aspart in Type 1 Diabetes (NCT00978627)
Diabetes Mellitus, Type 1: Comparison of NPH Insulin and Insulin Detemir in Children and Adolescents With Type 1 Diabetes (NCT00435019)
Diabetes Mellitus, Type 1: Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes (NCT00487240)
Diabetes Mellitus, Type 1: Efficacy and Safety of Inhaled Insulin in Type 1 Diabetes (NCT00308308)
Diabetes Mellitus, Type 1: Efficacy and Safety of Insulin Aspart vs. Human Insulin During Pregnancy by Women With Type 1 Diabetes (NCT00365170)
Diabetes Mellitus, Type 1: Efficacy and Safety of Insulin Detemir Versus NPH Insulin in Pregnant Women With Type 1 Diabetes. (NCT00474045)
Diabetes Mellitus, Type 1: Examining the Long-Term Safety of Insulin Aspart When Used as a Part of the Treatment for Type 1 Diabetes (NCT00832182)
Diabetes Mellitus, Type 1: Glulisine + Lantus in Type I Patients (NCT00546702)
Diabetes Mellitus, Type 1: Insulin Glulisine, Diabetes Mellitus Type 1 (NCT00397553)
Diabetes Mellitus, Type 1: Safety Follow-up on Children and Adolescents With Type 1 Diabetes Treated With Insulin Detemir. An Extension to Trial NN304-1689 (NCT00623194)
Diabetes Mellitus, Type 1: Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Type 1 Diabetes (NCT00447382)
Diabetes Mellitus, Type 1, Type 2: A 2-Month Safety Follow-Up Trial (NCT00741429)
Diabetes Mellitus, Type 1, Type 2: Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes (NCT00655044)
Diabetes Mellitus, Type 1, Type 2: Observational Study to Evaluate the Safety of Levemir® in Diabetes (NCT00659295)
Diabetes Mellitus, Type 1, Type 2: Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes (NCT00308737)
Diabetes Mellitus, Type 2: 12 Weeks Treatement With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients (NCT00789035)
Diabetes Mellitus, Type 2: 52-Week Add-on to Metformin Comparison of Saxagliptin and Sulphonylurea (NCT00575588)
Diabetes Mellitus, Type 2: A Comparative Study of Aleglitazar and Actos® in Patients With Type 2 Diabetes Mellitus and Class II Heart Failure. (NCT00461058)
Diabetes Mellitus, Type 2: A Comparison of the Effects of Aleglitazar and Actos on Renal Function on Patients With Type 2 Diabetes. (NCT00461006)
Diabetes Mellitus, Type 2: A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes (NCT00330473)
Diabetes Mellitus, Type 2: A Dose-Finding Study of RO4998452 in Patients With Diabetes Mellitus (NCT00800176)
Diabetes Mellitus, Type 2: A Glycemic Control Evaluation of Glimepiride Versus Rimonabant on Top of Metformin in Type 2 Diabetes (NCT00449605)
Diabetes Mellitus, Type 2: A Phase 3 Study of BMS-477118 in Combination With Metformin in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise (NCT00327015)
Diabetes Mellitus, Type 2: A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise (NCT00528372)
Diabetes Mellitus, Type 2: A Randomised, db, Placebo-controlled Study of BI 1356 for 18 Weeks Followed by a 34 Week Double-blind Extension Period (Placebo Patients Switched to Glimepiride) in Type 2 Diabetic Patients for Whom Treatment With Metformin is Inappropriate (NCT00740051)
Diabetes Mellitus, Type 2: A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects (NCT00454233)
Diabetes Mellitus, Type 2: A Study of Aleglitazar in Patients With Type 2 Diabetes (NCT00388518)
Diabetes Mellitus, Type 2: A Study of DPP-IV (3) in Patients With Type 2 Diabetes. (NCT00502710)
Diabetes Mellitus, Type 2: A Study of Taspoglutide Versus Exenatide for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, Thiazolidinedione or a Combination of Both. (NCT00717457)
Diabetes Mellitus, Type 2: A Study of Taspoglutide Versus Pioglitazone in Patients With Type 2 Diabetes (NCT00909597)
Diabetes Mellitus, Type 2: A Study of Taspoglutide Versus Placebo for the Treatment of Obese Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Monotherapy (NCT00823992)
Diabetes Mellitus, Type 2: A Study of Taspoglutide Versus Placebo for the Treatment of Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise. (NCT00744926)
Diabetes Mellitus, Type 2: A Study of the Safety, Tolerability and Effect on Glycemic Control of Taspoglutide Versus Insulin Glargine in Insulin Naive Type 2 Diabetic Patients Inadequately Controlled With Metformin Plus Sulphonylurea. (NCT00755287)
Diabetes Mellitus, Type 2: A Study to Determine the Safety and Efficacy of Albiglutide in Patients With Type 2 Diabetes. (NCT00838916)
Diabetes Mellitus, Type 2: A Study to Determine the Safety and Efficacy of Albiglutide in Subjects With Type 2 Diabetes. (NCT00839527)
Diabetes Mellitus, Type 2: An Efficacy and Safety Study of BMS-512148 in Combination With Metformin Extended Release Tablets (NCT00643851)
Diabetes Mellitus, Type 2: Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes (NCT00600626)
Diabetes Mellitus, Type 2: BI 10773 add-on to Metformin in Patients With Type 2 Diabetes (NCT00749190)
Diabetes Mellitus, Type 2: BI 10773 in Type Two Diabetes (T2D) Patients, Open Label Extension (NCT00881530)
Diabetes Mellitus, Type 2: BI 1356 in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes (NCT00602472)
Diabetes Mellitus, Type 2: Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus (NCT00539890)
Diabetes Mellitus, Type 2: Comparison of Biphasic Insulin Aspart 70/30, 50/50, and 30/70 in Subjects With Type 2 Diabetes (NCT00184574)
Diabetes Mellitus, Type 2: Comparison of NN1250 With Insulin Glargine Plus Insulin Aspart With/Without Metformin and With/Without Pioglitazone in Type 2 Diabetes (NCT00972283)
Diabetes Mellitus, Type 2: Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes (NCT00537303)
Diabetes Mellitus, Type 2: Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX) (NCT00377858)
Diabetes Mellitus, Type 2: Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus (NCT00299871)
Diabetes Mellitus, Type 2: Dose-Ranging Study In Subjects With Type 2 Diabetes Mellitus Who Are Treatment-Naive (NCT00495469)
Diabetes Mellitus, Type 2: Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) (NCT00500331)
Diabetes Mellitus, Type 2: Effect of Biphasic Insulin Aspart 30 on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00280046)
Diabetes Mellitus, Type 2: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes (NCT00331851)
Diabetes Mellitus, Type 2: Effect of Rimonabant and Metformin Combination on Glycemic Control in Patients With Type 2 Diabetes (NCT00690456)
Diabetes Mellitus, Type 2: Effects of LY2189265 on Glycemic Control in Patients With Type 2 Diabetes (NCT00791479)
Diabetes Mellitus, Type 2: Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up (NCT00309244)
Diabetes Mellitus, Type 2: Efficacy and Safety of 3 Doses of BI1356 in Type 2 Diabetes Patients (NCT00328172)
Diabetes Mellitus, Type 2: Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes (NCT00838903)
Diabetes Mellitus, Type 2: Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics (NCT00707993)
Diabetes Mellitus, Type 2: Efficacy and Safety of B I1356 vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes (NCT00601250)
Diabetes Mellitus, Type 2: Efficacy and Safety of Dapagliflozin, Added to Therapy of Patients With Type 2 Diabetes With Inadequate Glycemic Control on Insulin (NCT00673231)
Diabetes Mellitus, Type 2: Efficacy and Safety of Prandial Inhalation of Technosphere/Insulin in Combination With Metformin or Technosphere/Insulin Alone Versus 2 Oral Anti-Diabetic Agents in Subjects With Type 2 Diabetes (NCT00332488)
Diabetes Mellitus, Type 2: Efficacy and Safety of SYR-322 Combined With Pioglitazone in Treating Subjects With Type 2 Diabetes Mellitus. (NCT00328627)
Diabetes Mellitus, Type 2: Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3) (NCT00641056)
Diabetes Mellitus, Type 2: Efficacy of SYR-322 With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus (NCT00395512)
Diabetes Mellitus, Type 2: Efficacy of SYR-472 in Subjects With Type 2 Diabetes Mellitus (NCT00653185)
Diabetes Mellitus, Type 2: Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes (NCT00355849)
Diabetes Mellitus, Type 2: Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin (NCT00082407)
Diabetes Mellitus, Type 2: GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate (NCT00261352)
Diabetes Mellitus, Type 2: GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes (NCT00252876)
Diabetes Mellitus, Type 2: GLP-1 Agonist AVE0010 (Morning or Evening) in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin (NCT00712673)
Diabetes Mellitus, Type 2: GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation in Monotherapy (NCT00688701)
Diabetes Mellitus, Type 2: GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin (NCT00715624)
Diabetes Mellitus, Type 2: GLP-1 Agonist AVE0010 in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Sulfonylurea (NCT00713830)
Diabetes Mellitus, Type 2: GLP-1 Agonist AVE0010 Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin (NCT00707031)
Diabetes Mellitus, Type 2: G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study) (NCT00255645)
Diabetes Mellitus, Type 2: Insulin Glulisine in Type 2 Diabetic Patients (NCT00360698)
Diabetes Mellitus, Type 2: Lantus Versus Levemir Treat-To-Target (NCT00405418)
Diabetes Mellitus, Type 2: Long-Term Study of Nateglinide+Valsartan to Prevent or Delay Type II Diabetes Mellitus and Cardiovascular Complications (NCT00097786)
Diabetes Mellitus, Type 2: Observational Study of Safety and Effectiveness of NovoMix® 30 for the Treatment of Diabetes (NCT00659282)
Diabetes Mellitus, Type 2: Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin na??ve Subjects With Type 2 Diabetes (A1chieve Russia) (NCT00771680)
Diabetes Mellitus, Type 2: Opposing Step-by-step Insulin Reinforcement to Intensified Strategy (NCT00174642)
Diabetes Mellitus, Type 2: Placebo Controlled, Dose Escalation Study in Subjects With Type 2 Diabetes Mellitus Being Treated With Sulfonylurea (NCT00455598)
Diabetes Mellitus, Type 2: PPAR-COMBO With Sulfonylurea (NCT00162175)
Diabetes Mellitus, Type 2: Proof of Confidence Study of CCR2 Antagonist (BMS-741672) in Insulin Resistance (NCT00699790)
Diabetes Mellitus, Type 2: Randomized, db, Placebo-controlled 18 Week Study of BI 1356 in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug (NCT00819091)
Diabetes Mellitus, Type 2: RECORD: Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (NCT00379769)
Diabetes Mellitus, Type 2: Safety and Efficacy of BI 1356 as Monotherapy or in Combination in Type 2 DM (NCT00736099)
Diabetes Mellitus, Type 2: Safety and Efficacy of BI 1356 Plus Metformin in Type 2 Diabetes, Factorial Design (NCT00798161)
Diabetes Mellitus, Type 2: Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes (NCT00736879)
Diabetes Mellitus, Type 2: Safety and Efficacy of Exenatide as Monotherapy (NCT00381342)
Diabetes Mellitus, Type 2: Safety and Efficacy of Inhaled Pre-prandial Human Insulin in Type 2 Diabetes (NCT00343980)
Diabetes Mellitus, Type 2: Safety and Efficacy of Insulin Detemir in Combination With OAD in Type 2 Diabetes (NCT00604396)
Diabetes Mellitus, Type 2: Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients (NCT00929539)
Diabetes Mellitus, Type 2: Safety, Tolerability, and Activity of ISIS 113715 in People With Type 2 Diabetes Mellitus Who Have Not Received Prior Treatment (NCT00330330)
Diabetes Mellitus, Type 2: Study Comparing Muraglitazar With Glimepiride in Type 2 Diabetics Who Are Not Controlled With Metformin Alone (NCT00095030)
Diabetes Mellitus, Type 2: Study Evaluating PPM-204 In Subjects With Type 2 Diabetes (NCT00425919)
Diabetes Mellitus, Type 2: Study Evaluating Rimonabant Efficacy in Insulin-Treated Diabetic Patients(ARPEGGIO) (NCT00288236)
Diabetes Mellitus, Type 2: Study In People With Type 2 Diabetes (NCT00196989)
Diabetes Mellitus, Type 2: Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise (NCT00316082)
Diabetes Mellitus, Type 2: Study of Dapagliflozin in Combination With Metformin XR to Initiate the Treatment of Type 2 Diabetes (NCT00859898)
Diabetes Mellitus, Type 2: Study of Muraglitazar Versus Pioglitazone in Type 2 Diabetes (NCT00106808)
Diabetes Mellitus, Type 2: The ORIGIN Trial (Outcome Reduction With Initial Glargine Intervention) (NCT00069784)
Diabetes Mellitus, Type 2: To Compare the Effect of Liraglutide When Given Together With Metformin With the Effect of Metformin Given Alone and With the Effect of Glimepiride and Metformin Given Together (NCT00318461)
Diabetes Mellitus, Type 2: Treatment Effect of Saxagliptin Compared With Placebo in Patients With Type 2 Diabetes and Renal Impairment (NCT00614939)
Diabetes Mellitus, Type 2: Tulip Study: Testing the Usefulness of Lantus When Initiated Prematurely In Patients With Type 2 Diabetes (NCT00174681)
Diabetes Mellitus, Type 2, Acute Myocardial Infarction: Hyperglycemia and Cardiovascular Outcomes With Type 2 Diabetes (NCT00191282)
Diabetic Nephropathies, Hypertension: 1 Year Trial Telmisartan 80 mg Versus Valsartan 160 mg in Hypertensive Type 2 Diabetic Patients With Overt Nephropathy (NCT00153023)
Diabetic Neuropathy: Open-label, follow-on Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy. (NCT00546351)
Diabetic Polyneuropathy: Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (SYDNEY 2) (NCT00328601)
Diabetic Retinopathy: Reduction in the Occurrence of Center-Involved Diabetic Macular Edema (NCT00090519)
Diagnostic Imaging: PMS Study Ultravist-IMAGE, IoproMide (UltrAvist) to Gain Further Information on Tolerability and Safety in X-ray Examination (NCT00876083)
Digestive Fistulae: Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae (NCT00729313)
Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type b Disease: Compare Immunogenicity and Safety of 2 Formulations of GSK Biologicals DTPa-HBV-IPV/Hib Vaccine Given in Healthy Infants (NCT00320463)
Diphtheria, Tetanus, Pertussis, Hepatitis B, Poliomyelitis, Haemophilus Influenzae Type b Disease: Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children (NCT00611559)
Dyslipidaemia: Study In Patients With Dyslipidaemia (NCT00264667)
Dyslipidemia: Safety and Efficacy of TAK-475 Taken Alone and With Atorvastatin in Subjects With Primary Dyslipidemia (NCT00487994)
Endometriosis: A Multinational, Randomized, Double-Blind, Placebo?€‘Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed Endometriosis (NCT00244452)
Endometriosis: Pain Associated With Endometriosis (NCT00758953)
Epilepsies, Partial: Open-Label Extension Study of the Phase 3 VRX-RET-E22-302 Double-Blind Trial (NCT00310388)
Epilepsies, Partial: Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy (NCT00235755)
Epilepsy: A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR (NCT00368069)
Epilepsy: Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures (NCT00692003)
Epilepsy: Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures (NCT00515619)
Epilepsy: Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy (NCT00504881)
Epilepsy: Conversion to Monotherapy Study With Keppra XR for Partial Seizures (NCT00419094)
Epilepsy: Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy (NCT00693017)
Epilepsy: Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy (NCT00175903)
Epilepsy: Long Term Follow-up Study With Levetiracetam XR (Keppra XR) for Partial Seizures (NCT00419393)
Epilepsy: Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures (NCT00113165)
Epilepsy, Partial: A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures. (NCT00175890)
Epilepsy, Partial: Conversion To Monotherapy With Lamictal Extended Release Tablets For Treatment Of Partial Epilepsy (NCT00355082)
Epilepsy, Partial: Follow-up Trial to Evaluate Long-term Safety and Efficacy of Brivaracetam in Subjects Suffering From Epilepsy (NCT00175916)
Epilepsy, Partial: Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures (NCT00152516)
Epilepsy, Partial Seizures: Efficacy, Safety, and Tolerability of Oxcarbazepine Monotherapy in Children With Partial Seizures (NCT00275912)
Epilepsy, Partial Seizures: Safety and Efficacy of Oxcarbazepine Monotherapy in Adults With Partial Seizures (NCT00275925)
Epilepsy, Refractory: Safety and Efficacy of 333369 in the Treatment of Partial Epilepsy (NCT00228969)
Epilepsy, Seizures: Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy. (NCT00563459)
Erectile Dysfunction: A Study to Evaluate Self-Esteem and Relationships in Males With Erectile Dysfuntion (NCT00648596)
Erectile Dysfunction: Efficacy and Safety of Vardenafil in Men With Erectile Dysfunction (NCT00657644)
Esophagitis, Reflux, Esophagitis, Peptic: Efficacy and Safety of Dexlansoprazole and Lansoprazole on Healing of Erosive Esophagitis (NCT00251719)
Essential Hypertension: Efficacy and Safety of TAK-491 and Chlorthalidone in Subjects With Moderate to Severe Hypertension (NCT00818883)
Essential Hypertension: Efficacy and Safety Study of TAK-491 Compared to Ramipril for Treating Essential Hypertension (NCT00760214)
Excessive Daytime Sleepiness, Narcolepsy: Extension Study of the Safety and Efficacy of CEP-10953 in the Treatment of Patients With Excessive Sleepiness (NCT00228553)
Foot Ulcer: Efficacy of Soluble Beta-1,3/1,6-Glucan Compared to Placebo on Chronic Leg Ulcers in Diabetes Patients (NCT00288392)
Foot Ulcer, Diabetic: Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers (NCT00448903)
Gastric Cancer: Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer (NCT00415168)
Gastric Cancer: ToGA Study - A Study of Herceptin (Trastuzumab) in Combination With Chemotherapy Compared With Chemotherapy Alone in Patients With HER2-Positive Advanced Gastric Cancer (NCT01041404)
Gastric Ulcer, Duodenal Ulcer: Study of Esomeprazole 20 mg or 40 mg vs Placebo Effectiveness on the Occurrence of Peptic Ulcers in Subjects on LDA (NCT00441727)
Gastroesophageal Reflux Disease: Rabeprazole Extended-Release, 50 mg, Versus Esomeprazole, 40 mg, for Healing and Symptomatic Relief of Moderate to Severe Erosive Gastroesophageal Reflux Disease (GERD) (NCT00658775)
Gastrointestinal Hemorrhage: A Study to Prevent Rebleeding After Initial Successful Primary Endoscopic Haemostasis of a Bleeding Peptic Ulcer (NCT00251979)
Gaucher Disease, Type 1: A Study of GA-GCB Enzyme Replacement Therapy in Gaucher Disease (NCT00430625)
Gaucher Disease, Type 1: A Study of the Efficacy and Safety of Genz-112638 in Type 1 Gaucher Patients (NCT00358150)
Gaucher Disease, Type 1: An Open-Label Extension Study of GA-GCB ERT in Patients With Type 1 Gaucher Disease (NCT00635427)
Gaucher Disease, Type 1: Study of Gene-Activated® Human Glucocerebrosidase (GA-GCB) ERT Compared With Imiglucerase in Type I Gaucher Disease (NCT00553631)
Generalized Anxiety Disorder: A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1) (NCT00658008)
Generalized Anxiety Disorder: A 10-Week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2) (NCT00658372)
Generalized Anxiety Disorder: Efficacy and Safety of Escitalopram in Patients With Generalized Anxiety Disorder (NCT00902564)
Generalized Anxiety Disorder: Efficacy and Safety of Lu AA21004 for Treatment of Generalized Anxiety Disorder in Adults. (NCT00744627)
Generalized Anxiety Disorder: Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). (NCT00413010)
Generalized Anxiety Disorder: Relapse-prevention Study With Lu AA21004 in Patients With Generalized Anxiety Disorder (NCT00788034)
Glaucoma: A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. (NCT00716859)
Glioblastoma: Study of IV Edotecarin Vs Temozolomide or Carmustine (BCNU) or Lomustine (CCNU) in Patients With Glioblastoma Multiforme (NCT00068952)
Gout: Evaluating Efficacy of Canakinumab (ACZ885) in Prevention of Acute Flares in Chronic Gout Patients Initiating Allopurinol Therapy (NCT00819585)
Growth Hormone Deficiency: Predictive Markers in GHD and TS Children Treated With SAIZEN® (NCT00256126)
Hayfever Allergic Rhinitis Seasonal Rhinitis: Study In Adults And Adolescents With Seasonal Allergic Rhinitis (NCT00225823)
Head and Neck Cancer: Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME) (NCT00122460)
Head and Neck Cancer, Squamous Cell Cancer: Zalutumumab in Patients With Non-Curable Head and Neck Cancer (NCT00382031)
Head and Neck Neoplasms: A Study for Patients With Head and Neck Cancer (NCT00415194)
Head and Neck Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis: Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT00401323)
Healthy: Immediate Effect of Light on Reproductive Hormones in Women: a Role of the Spectrum (NCT00467805)
Healthy, Infant: Immune Response Post Pry Vaccination of 2 Formulations of DTPw-HBV Vaccine Given With Rotavirus Vaccine to Infants (NCT00158756)
Heart Defects, Congenital: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of MEDI-524 (NCT00240890)
Heart Defects, Congenital: Efficacy And Safety Of Clopidogrel In Neonates /Infants With Systemic To Pulmonary Artery Shunt Palliation (NCT00396877)
Heart Defects, Congenital: Long Term Safety of Clopidogrel in Neonates/Infants With Systemic to Pulmonary Artery Shunt Palliation (NCT00833703)
Heart Disease: A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease (NCT00538785)
Heart Failure: A Study of CK-1827452 Infusion in Stable Heart Failure (NCT00624442)
Heart Failure: Crestor Versus Placebo in Subjects With Heart Failure (NCT00206310)
Heart Failure: Safety/Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of LCZ696 in Patients With Stable Heart Failure (NCT00913653)
Heart Failure, Myocardial Ischemia, Angina Pectoris: Pharmacokinetics (PK) And Tolerability of Intravenous (IV) and Oral CK-1827452 in Patients With Ischemic Cardiomyopathy (NCT00682565)
Hemophilia A: Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A (NCT00243386)
Hemophilia A: Russian Kogenate Pediatric Study (NCT00632814)
Hemophilia A: Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. (NCT00245297)
Hemophilia A, Hemophilia B: Efficacy of NovoSeven® in Bleeding Prophylaxis in Hemophilia (NCT00108758)
Hemophilia B: Study Comparing On-Demand Treatment With Two Prophylaxis Regimens of BeneFIX in Patients With Severe Hemophilia B (NCT00364182)
Hepatitis B: Comparison of Entecavir to Adefovir in Chronic Hepatitis B Virus (HBV) Patients With Hepatic Decompensation (NCT00065507)
Hepatitis B: Study of Entecavir in Patients With Chronic Hepatitis B Virus (HBV) Infection (NCT00388674)
Hepatitis B, Chronic: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. (NCT00487747)
Hepatitis B, Chronic: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB). (NCT00435825)
Hepatitis B, Chronic: Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B (NCT00410072)
Hepatitis C: Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects (NCT00244751)
Hepatitis C: Omega Interferon Alone or in Combination With Ribavirin in Subjects With Hepatitis C (NCT00097045)
Hepatitis C: Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment Naive (NCT00093093)
Hepatitis C, Chronic: A Study of Induction Dosing With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C. (NCT00394277)
Hepatitis, Hepatitis B, Chronic, Cirrhosis: Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis (NCT00076336)
Hepatocellular Carcinoma: T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients (NCT00057382)
Hepatocellular Carcinoma : A Phase III Randomized, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (NCT00105443)
Hepatocellular Carcinoma : A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma (NCT00108953)
Hepatocellular Carcinoma : Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer (NCT00034333)
Heroin Dependence, Opioid-Related Disorders: Addiction Treatment in Russia: Oral vs. Naltrexone Implant (NCT00218426)
HIV Infection: A Study of Patient Management in HIV-1 Infected Patients Found to Have the Genetic Marker HLA-B*5701 (NCT00435838)
HIV Infection: Clinical Utility Of Genetic Screening For HLA-B*5701, On Susceptibility To Abacavir Hypersensitivity (NCT00340080)
HIV Infections: A Comparison of BMS-232632 With Efavirenz, Each in Combination With Zidovudine-Lamivudine (NCT00013897)
HIV Infections: A Randomised Trial to Evaluate the Antiviral Efficacy and Safety of Treatment With 500 mg Tipranavir (TPV) Plus 100 mg or 200 mg Ritonavir (RTV) p.o. BID in Comparison to 400 mg Lopinavir (LPV) Plus 100 mg RTV p.o. BID in Combination With Standard Background Regimen in ARV Therapy na??ve Patients. (NCT00144105)
HIV Infections: Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients (NCT00005918)
HIV Infections: HIV Prevention Preparedness Study in Russia, China, and India (NCT00021775)
HIV Infections: HIV Prevention Within High-Risk Bulgarian and Hungarian Social Networks (NCT00310973)
HIV Infections: Induction-Maintenance With Atazanavir in HIV Na??ve Patients (The INDUMA Study) (NCT00207142)
HIV Infections: VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients (NCT00561925)
HIV Infections, AIDS: Rollover Study for Zerit (Stavudine) ER Studies (-096, -099) (NCT00116298)
HIV Infections, Sexually Transmitted Diseases: Effectiveness of a Community-Level HIV/STD Prevention Intervention in Promoting Safer Sexual Behaviors in High-Risk Populations (NCT00710060)
HIV-1 Infection: A Dose Ranging Trial of GSK1349572 and 2 NRTI in HIV-1 Infected, Therapy Naive Subjects (NCT00951015)
HIV-1 Infection: HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults (NCT00450580)
Hormone Refractory Prostate Cancer: A Study Comparing AT-101 in Combination With Docetaxel and Prednisone Versus Docetaxel and Prednisone in Men With Chemotherapy-Naive Metastatic Hormone Refractory Prostate Cancer (HRPC) (NCT00571675)
Hormone Refractory Prostate Cancer: A Study of Picoplatin and Docetaxel in Subjects With Prostate Cancer (NCT00448734)
Hormone Refractory Prostate Cancer: Study on Prolonging Bone Metastasis-Free Survival in Men With Hormone Refractory Prostate Cancer (NCT00286091)
Hot Flushes, Menopause, Postmenopause: Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes (NCT00160342)
HPV Infections and Associated Cervical Neoplasia: Study to Evaluate the Efficacy of the Human Papillomavirus Vaccine in Healthy Adult Women of 26 Years of Age and Older (NCT00294047)
HPV-16/18 Infections, Cervical Neoplasia: Human Papilloma Virus Vaccine Consistency and Non-Inferiority Trial in Young Adult Women With GSK Bio HPV-16/18 (NCT00169494)
Hydronephrosis, Neurogenic Bladder: Alfuzosin Treatment in Children and Adolescents With Hydronephrosis of Neuropathic Etiology (NCT00576823)
Hypercholesterolemia: A Study Evaluating the Safety and Efficacy of AVE5530 (4 Weeks) in Patients With Mild to Moderate Hypercholesterolemia (NCT00440154)
Hypercholesterolemia: Efficacy of Lapaquistat on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia (NCT00532558)
Hypercholesterolemia: Efficacy of TAK-475 Alone and With Ezetimibe in Subjects With Primary Dyslipidemia. (NCT00268697)
Hypercholesterolemia: Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia (NCT00766688)
Hypercholesterolemia: Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing Statins in Patients With Primary Hypercholesterolemia (NCT00729027)
Hypercholesterolemia, Dyslipidemia: Long-Term (1 Year) Extension Study of Pitavastatin in Patients With Primary Hypercholesterolemia or Combined Dyslipidemia (NCT00325780)
Hypercholesterolemia, Dyslipidemia: Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin (NCT00309777)
Hypercholesterolemia, Dyslipidemia: Study to Compare the Efficacy of Pitavastatin With That of Atorvastatin in Lowering Cholesterol Levels (NCT00249249)
Hyperlipidemia: Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin (NCT00362206)
Hyperparathyroidism, Secondary, Chronic Kidney Disease: E.V.O.L.V.E. TrialTM: EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (NCT00345839)
Hypertension: 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension (NCT00624052)
Hypertension: A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. (NCT00147589)
Hypertension: An Open Label Extension to Study CVAL489K2303 to Evaluate the Long Term Use of Valsartan in 6 Months - 5 Year Old Hypertensive Children (NCT00457626)
Hypertension: Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo (NCT00434967)
Hypertension: AVE7688 in Patients With Mild to Moderate Blood Pressure (NCT00284128)
Hypertension: Caduet vs Usual Care in Subjects With Hypertension and Additional Risk Factors (NCT00407537)
Hypertension: Extension Study to Assess Long Term Safety, Tolerability and Efficacy of Valsartan and Enalapril Combined and Alone in Children With Hypertension (NCT00446511)
Hypertension: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension (NCT00095394)
Hypertension: Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients With Moderate Hypertension (NCT00095550)
Hypertension: Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Amlodipine in Essential Hypertension (NCT00739973)
Hypertension: Telmisartan and Amlodipine Fixed Dose Combination Trial for the Treatment of Severe Hypertension (NCT00860262)
Hypertension: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension (NCT00553267)
Hypertension: The Hypertension in the Very Elderly Trial (HYVET) (NCT00122811)
Hypertension: The Long-Term Study to Evaluate the Safety of Eplerenone in the Treatment of Hypertension in Children Aged 6 to 16 Years (NCT00147615)
Hypertension, Dyslipidemia: Efficacy and Safety of Fluvastatin or Valsartan and Their Combination in Dyslipidemic Patients With Hypertension and Endothelial Dysfunction (NCT00171327)
Hypertension, Dyslipidemias: Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia (NCT00316095)
Hypertension, Pulmonary: BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial Hypertension (NCT00863681)
Hypertensive Urgency: Risk Factors of Hypertensive Urgencies (NCT00421239)
Hypogonadism: Nebido Versus Placebo in Elderly Men With Typical Symptoms of Late Onset Hypogonadism Over a Period of 54 Weeks (NCT00710827)
Hysterectomy, Abdominal Pain Assessment, Visceral Pain: A Study to Evaluate the Efficacy and Safety of CG5503 in the Treatment of Acute Pain After Abdominal Hysterectomy Compared With Morphine and Placebo (NCT00478023)
Idiopathic Cervical Dystonia: Factors Influencing Response to One BoNT-A Injection Cycle in Subjects Suffering From Idiopathic Cervical Dystonia (NCT00833196)
Idiopathic Menorrhagia: Mirena in Idiopathic Menorrhagia (NCT00868153)
Idiopathic Thrombocytopenic Purpura: RAISE: Randomized Placebo-Controlled Idiopathic Thrombocytopenic Purpura (ITP) Study With Eltrombopag (NCT00370331)
Idiopathic Thrombocytopenic Purpura: Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT) (NCT00424177)
Immune Thrombocytopenic Purpura: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Refractory Immune Thrombocytopenic Purpura (ITP) (NCT00102739)
Impotence: Study to Evaluate Viagras Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction (NCT00245258)
Impotence: Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function. (NCT00249730)
Inappropriate ADH Syndrome, Hyponatremia: Safety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (NCT00264914)
Infection: Therapy of Complicated Intra-Abdominal Infections With Moxifloxacin or Ertapenem (NCT00492726)
Influenza: Study to Demonstrate the Lot-to-Lot Consistency and to Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate (NCT00321763)
Influenza: Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged 18 Years and Above (NCT00319098)
Influenza Disease: Trial to Evaluate the Efficacy of GSK Biologicals Influenza Vaccine GSK2186877A in Adults 65 Year of Age and Older (NCT00753272)
Intermittent Claudication: Efficacy and Safety of HMR1766 in Patients With Fontaine Stage II Peripheral Arterial Disease (NCT00443287)
Intermittent Claudication: Mixed Antagonist of Serotonin for Claudication Optimal Therapy (NCT00300339)
Intermittent Claudication: Safety and Efficacy of K-134 for the Treatment of Intermittent Claudication (NCT00783081)
Iron Deficiency Anemia: 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients. (NCT00223977)
Irritable Bowel Syndrome: A Study of YM060 in Diarrhea-Predominant Irritable Bowel Syndrome (d-IBS) (NCT00189813)
Irritable Bowel Syndrome: Ibodutant for Relief of Irritable Bowel Syndrome (IRIS) (NCT00761007)
Ischemic Stroke: Granulocyte-Colony Stimulating Factor for Stem Cells Therapy for Acute Ischemic Stroke (NCT00901381)
Kidney Cancer: Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer (NCT00002737)
Kidney Transplantation: A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection (NCT00717470)
Kidney Transplantation, Kidney Failure, Chronic, Renal Insufficiency, Chronic: Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation (NCT00717379)
Labor, Induced: Recombinant Human Relaxin (rhRlx) in Pregnant Women Scheduled for Induction of Labor (NCT00259103)
Lower Urinary Tract Symptoms, Prostatic Hyperplasia: A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH (NCT00510406)
Lymphoma, Large Cell, Diffuse: Chemotherapy for Patients With Lymphoma (NCT00436280)
Lymphoma, Non-Hodgkin: BBR 2778 for Relapsed, Aggressive Non-Hodgkins Lymphoma (NHL) (NCT00088530)
Lymphoma, Non-Hodgkins: A Study of Galiximab + Rituximab Versus Rituximab + Placebo in Follicular Non-Hodgkins Lymphoma (NHL) (NCT00363636)
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome: Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients (NCT00050999)
Lymphoma, T-Cell, Cutaneous, Mycosis Fungoides, Sezary Syndrome: Study of ONTAK (Denileukin Diftitox) in Previously Treated Cutaneous T-Cell Lymphoma Patients (NCT00051012)
Macular Degeneration: Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) (NCT00414206)
Major Depressive Disorder: An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly Patients (NCT00822744)
Macular Degeneration, Age Related: Safety Study of 16.5mg (3.3%) CGC-11047 Injected Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to Age Related Macular Degeneration (NCT00446654)
Major Depressive Disorder: A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression (NCT00422162)
Major Depressive Disorder: A Study of GW856553X For the Treatment of Depression (NCT00569062)
Major Depressive Disorder: Dose-Finding Study With Lu AA24530 in Major Depressive Disorder (NCT00599911)
Major Depressive Disorder: Efficacy and Safety of Lu AA21004 in Adults With Major Depressive Disorder (NCT00735709)
Major Depressive Disorder: Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder (NCT00388973)
Major Depressive Disorder: Major Depressive Disorder In The Elderly (NCT00093288)
Major Depressive Disorder: Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder (NCT00278941)
Major Depressive Disorder: Safety and Tolerability of Lu AA21004 in Subjects With Major Depressive Disorder (NCT00707980)
Major Depressive Disorder: Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder (NCT00807248)
Major Depressive Disorder, Insomnia: A Study of Eszopiclone Co-administered With Venlafaxine in Subjects With Major Depressive Disorder and Insomnia (NCT00435279)
Major Depressive Disorders: Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder (NCT00855530)
Measles, Mumps, Rubella, Chickenpox: Evaluate Vaccine Agst Chickenpox and a Comb Vaccine Agst 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox. (NCT00226499)
Melanoma: A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies (NCT00162123)
Melanoma: A Single Arm Study of Ipilimumab Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma (NCT00289627)
Melanoma: CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy (NCT00257205)
Melanoma: Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma (NCT00324155)
Melanoma (Skin): High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III Melanoma (NCT00002763)
Melanoma (Skin): Vaccine Therapy in Treating Patients With Primary Stage II Melanoma (NCT00005052)
Melanoma, Malignant: Study of Heat Shock Protein-Peptide Complex (HSPPC-96) Versus IL-2/DTIC for Stage IV Melanoma (NCT00039000)
Metabolic Syndrome, Hypertension: Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome (NCT00110422)
Multiple Myeloma: Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects With Multiple Myeloma (NCT00057564)
Multiple Myeloma, Newly Diagnosed : A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older (NCT00405756)
Multiple Sclerosis: A Study of A4I Antagonist in Patients With Relapsing Multiple Sclerosis. (NCT00104143)
Multiple Sclerosis: BRAVO Study: Laquinimod Double Blind Placebo Controlled Study in RRMS Patients With a Rater Blinded Reference Arm of Interferon beta-1a (Avonex®) (NCT00605215)
Multiple Sclerosis: Efficacy and Safety of BG00012 in MS (NCT00168701)
Multiple Sclerosis: Efficacy and Safety of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis (NCT00289978)
Multiple Sclerosis: REbif FLEXible Dosing in Early Multiple Sclerosis (MS) (NCT00404352)
Multiple Sclerosis: Safety and Efficacy of Orally Administered Laquinimod for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS) (NCT00509145)
Multiple Sclerosis: Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis (NCT00532532)
Multiple Sclerosis: Study of Teriflunomide in Reducing the Frequency of Relapses and Accumulation of Disability in Patients With Multiple Sclerosis (NCT00134563)
Multiple Sclerosis: Three Months Treatment With SB683699 In Patients With Relapsing Multiple Sclerosis (NCT00097331)
Multiple Sclerosis, Relapsing-Remitting: A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis (NCT00050778)
Multiple Sclerosis, Relapsing-Remitting: An Extension Protocol for Multiple Sclerosis Patients Who Participated in Genzyme-Sponsored Studies of Alemtuzumab (NCT00930553)
Multiple Sclerosis, Relapsing-Remitting: BEYOND Follow-up: Betaferon®/Betaseron® Efficacy Yielding Outcomes of a New Dose (NCT00459667)
Multiple Sclerosis, Relapsing-Remitting: BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients (NCT00099502)
Multiple Sclerosis, Relapsing-Remitting: Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study One (NCT00530348)
Multiple Sclerosis, Relapsing-Remitting: Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study Two (NCT00548405)
Multiple Sclerosis, Relapsing-Remitting: Long Term Safety and Efficacy Study of Teriflunomide 7 mg or 14 mg in Patients With Relapsing-Remitting Multiple Sclerosis (NCT00803049)
Muscle Weakness, Critical Illness: Critical Illness Neuromuscular Abnormalities in Neurocritical Care Patients (NCT00893633)
Myasthenia Gravis, Generalized: A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia Gravis (NCT00683969)
Myelodysplastic Syndromes: A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care (NCT00071799)
Myeloid Leukemia, Acute: Study of CEP-701 in Patients With Acute Myeloid Leukemia (AML) (NCT00079482)
Myeloid Leukemia, Acute: Trial of Decitabine in Patients With Acute Myeloid Leukemia (NCT00260832)
Myocardial Infarction: Extension 1 to Protocol CSPP100A2340: Study to Evaluate the Efficacy and Safety of Aliskiren on the Prevention of Left Ventricular Remodeling in High Risk Post-acute Myocardial Infarction Patients When Added to Optimized Standard Therapy (NCT00699075)
Myocardial Infarction: MICHELANGELO OASIS-6 : FOndaparinux in ST Elevation Myocardial Infarction (NCT00064428)
Myocardial Infarction: Safety and Efficacy of Aliskiren in Post Myocardial Infarction Patients (ASPIRE) (NCT00414609)
Myocardial Infarction, Acute: Study of ARC1779 in Patients With Acute Myocardial Infarction Undergoing PCI (NCT00507338)
Myocardial Infarction, Acute ST-Segment Elevation: Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) (NCT00077792)
Narcolepsy, Sleep Apnea, Obstructive, Sleep Apnea Syndromes, Shift-Work Sleep Disorder: CEP-10953 for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder (NCT00078312)
Neoplasms, Glandular and Epithelial: Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial Origin (NCT00481936)
Neoplasms, Prostatic Neoplasms: XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancer (NCT00417079)
Neuralgia, Postherpetic: Efficacy, Safety and Tolerability Study of TAK-583 in Subjects With Postherpetic Neuralgia (NCT00377598)
Neuralgia, Postherpetic: PH-797804 Versus Placebo For The Treatment Of Neuropathic Pain Associated With Post-Herpetic Neuralgia (NCT00614705)
Neuralgia, Postherpetic: Safety and Efficacy of Gabapentin in Postherpetic Neuralgia (NCT00636636)
Neurogenic Urinary Bladder: Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction (NCT00549939)
Neuropathic Pain, Nerve Trauma: P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain (NCT00390845)
Non Small Cell Lung Cancer: A Randomized Phase 2 Study of Erlotinib + ARQ 197 Versus Erlotinib + Placebo in Previously Treated Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00777309)
Non Small Cell Lung Cancer: Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy (NCT00456833)
Non Small Cell Lung Cancer: Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer(FLEX) (NCT00148798)
Non Small Cell Lung Cancer: Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer (NCT00347412)
Non Small Cell Lung Carcinoma: A Phase 3 Trial of LY900003 Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Patients With Advanced, Previously Untreated Non-Small Cell Lung Cancer (NCT00034268)
Non Small Cell Lung Carcinoma: A Randomized Controlled Trial Comparing Safety and Efficacy of Carboplatin and Paclitaxel Plus or Minus Sorafenib (BAY 43-9006) in Chemonaive Patients With Stage IIIB-IV Non-Small Cell Lung Cancer (NSCLC) (NCT00300885)
Non Small Cell Lung Carcinoma: A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone (NCT00457392)
Non Small Cell Lung Carcinoma: ABR-217620 in Combination With Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer (NCT00132379)
Non Small Cell Lung Carcinoma: Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy (NCT00191841)
Non Small Cell Lung Carcinoma: Safety and Efficacy of S-8184 in Second Line Treatment of Relapsed Stage IIIB or IV Non Small Cell Lung Cancer (NCT00034164)
Non-Hodgkins Lymphoma: Effect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkins Lymphoma (NCT00090038)
Non-Hodgkins Lymphoma: MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkins Lymphoma. (NCT00430352)
Non-Hodgkins Lymphoma: Retreatment Study of Galiximab + Rituximab in Follicular Non-Hodgkins Lymphoma (NHL) (NCT00384150)
Non-Hodgkins Lymphoma: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkins Lymphoma (NCT00312845)
Non-Hodgkins Lymphoma, Hodgkin Disease, Thrombocytopenia: Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia (NCT00039910)
Non-Small Cell Lung Cancer: A Randomized Phase 2 Study of AT-101 in Combination With Docetaxel in Relapsed/Refractory Non-Small Cell Lung Cancer (NCT00544960)
Non-Small Cell Lung Cancer: A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer. (NCT00700180)
Non-Small Cell Lung Cancer: A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer (NCT00404703)
Non-Small Cell Lung Cancer: A Study of Avastin (Bevacizumab) in Combination With Platinum-Containing Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Cell Lung Cancer. (NCT00451906)
Non-Small Cell Lung Cancer: A Study of Avastin (Bevacizumab) in Patients With Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (NCT00806923)
Non-Small Cell Lung Cancer: A Study of Tarceva (Erlotinib) Following Platinum-Based Chemotherapy in Patients With Advanced, Recurrent, or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00556712)
Non-Small Cell Lung Cancer: A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00112060)
Non-Small Cell Lung Cancer: A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy. (NCT00269828)
Non-Small Cell Lung Cancer: An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin (NCT00274443)
Non-Small Cell Lung Cancer: Docetaxel With or Without Oblimersen in Treating Patients With Non-Small Cell Lung Cancer (NCT00030641)
Non-Small Cell Lung Cancer: Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NCT00050973)
Non-Small Cell Lung Cancer: Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study (NCT00242801)
Non-Small Cell Lung Cancer: Study of the Effect on Non-Small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere) (NCT00373204)
Non-Small Cell Lung Cancer, Fatigue, Cachexia: Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-Related Fatigue and Cachexia (NCT00866970)
Non-Small-Cell Lung Cancer: Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer (NCT00049998)
Non-Squamous Non-Small-Cell Lung Cancer: A Study of Paclitaxel/Carboplatin With or Without CDP791 in Patients With Lung Cancer (NCT00152477)
Obesity: A Study of Xenical (Orlistat) in Overweight and Obese Adolescents (NCT00940628)
Obesity: Efficacy and Safety of THR-4109 in Obese Subjects (NCT00485017)
Obesity: Weight Loss in Pre-diabetic, Obese Women (NCT00686816)
Onychomycosis: Efficacy, Safety and Tolerability of Topical 10% Terbinafine Hydrogen Chloride Versus 5% Amorolfine Nail Lacquer in Patients With Mild to Moderate Toenail Onychomycosis (NCT00459537)
Opiate Dependence: Efficacy and Safety of Vivitrol® in Adults With Opioid Dependence (NCT00678418)
Osteoarthritis Knee Pain: Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain (NCT00433290)
Osteoarthritis, Arthritis, Rheumatoid: Assessing the Impact of MOVALIS in Osteoarthritis and Rheumatoid Arthritis Patients on Health Related Quality of Life (NCT00619177)
Osteoarthritis, Arthritis, Rheumatoid: Study Of Celecoxib Or Diclofenac And Omeprazole For Gastrointestinal (GI) Safety In High GI Risk Patients With Arthritis (NCT00141102)
Osteolytic Lesions of Multiple Myeloma: A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma (NCT00747123)
Osteopenia: To Assess the Efficacy of Over-the-Counter Analgesics in the Prevention/Treatment of Transient Post-Dose Symptoms Following Zoledronate Infusion in Post-Menopausal Women (NCT00145275)
Osteoporosis: A Dose-Ranging Study of MK5442 in Postmenopausal Women With Osteoporosis (NCT00960934)
Osteoporosis: Open Label Extension Study of PREOS (NCT00172133)
Osteoporosis: Postmenopausal Evaluation and Risk-reduction With Lasofoxifene (PEARL) (NCT00141323)
Osteoporosis: TOP: Trial of the Effect of Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis (NCT00172081)
Osteoporosis, Male: Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis (NCT00439647)
Osteoporosis, Postmenopausal : 3-Year Efficacy and Safety Study of Zoledronic Acid in Post-Menopausal Women With Osteoporosis Treated With Zoledronic Acid for 6 Years (NCT00718861)
Osteoporosis, Postmenopausal : A Phase II Study Evaluating SB-751689 in Post-Menopausal Women With Osteoporosis. (NCT00471237)
Osteoporosis, Postmenopausal : A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP). (NCT00545363)
Osteoporosis, Postmenopausal : Study of Teriparatide in the Treatment of Postmenopausal Women With Osteoporosis (NCT00532207)
Otitis Media, Acute: A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections (NCT00643292)
Ovarian Cancer: Assessment of Efficacy of AZD2281 in Platinum Sensitive Serous Ovarian Cancer (NCT00753545)
Ovarian Cancer: Gemcitabine in Ovarian Cancer (NCT00191334)
Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Neoplasm: Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo (Sugar Pill) (NCT00391118)
Ovarian Cancer, Ovarian Neoplasms: AZD0530 Phase II Study in Patients With Advanced Ovarian Cancer (NCT00610714)
Ovarian Cysts, Endometriosis, Adhesions: Evaluation of Adhexil Safety and Efficacy in Prevention and/or Reduction of Adhesions in Gynecological Surgery (NCT00865488)
Overactive Bladder: A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON) (NCT00337090)
Overactive Bladder: Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine ER in Patients With Overactive Bladder. (NCT00611026)
Overactive Bladder: Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) (NCT00444925)
Overactive Bladder: Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder (NCT00311376)
Overactive Bladder, Detrusor Overactivity: A Study To Assess If 10 mg Vardenafil (BAY 38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function (NCT00478881)
Overactive Bladder, Urinary Incontinence, Urge Incontinence: A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) (NCT00337558)
Pain: [S,S]-Reboxetine Add-On Trial (NCT00334685)
Pain: [S,S]-Reboxetine Long Term Safety Study In Chronic Painful Diabetic Peripheral Neuropathy. (NCT00348894)
Pain: A Study Comparing the Efficacy and Safety of Valdecoxib Plus Parecoxib Versus Valdecoxib Plus Placebo for the Treatment of Pain After Coronary Artery Bypass Surgery (NCT00636064)
Pain, Bone Neoplasms, Neoplasm Metastasis: A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease (NCT00099203)
Pain, Bone Neoplasms, Neoplasm Metastasis: A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain (NCT00099177)
Pancreatic Cancer: Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery (NCT00499265)
Pancreatic Cancer: Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer (NCT00099294)
Pancreatic Ductal Carcinoma: Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer. (NCT00471146)
Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis: Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis (NCT00630279)
Pancreatic Neoplasm: Aflibercept Compared to Placebo in Term of Efficacy in Patients Treated With Gemcitabine for Metastatic Pancreatic Cancer (NCT00574275)
Pancreatic Neoplasms: Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen (NCT00417209)
Parkinsons Disease: A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinsons (NCT00331149)
Parkinsons Disease: Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients (NCT00479401)
Parkinsons Disease: First Presentation of Parkinson Disease Patients to Neurologist (NCT00802178)
Parkinsons Disease: Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD (NCT00577460)
Parkinsons Disease: Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson??s Disease (PD). (NCT00601523)
Parkinsons Disease: Pivotal Study in Advanced Parkinsons Disease Patients (NCT00466167)
Parkinsons Disease Psychosis: A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinsons Disease Psychosis (NCT00477672)
Parkinsons Disease, Advanced Stage: An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinsons Disease Experiencing Motor Fluctuations (NCT00407095)
Parkinsons Disease, Advanced Stage: SLV308 for Treatment of Patients With Parkinsons Disease Experiencing Motor Fluctuations (NCT00406588)
Parkinsons Disease, Depression: Pramipexole Versus Placebo in PD Patients With Depressive Symptoms (NCT00297778)
Parkinsons Disease, Early Stage : An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD Patients (NCT00332917)
Parkinsons Disease, Early Stage : SLV308 for Treatment of Patients With Early Parkinsons Disease (NCT00269516)
Perennial Allergic Rhinitis: A Clinical Study To Test A Nasal Spray (Fluticasone Furoate Nasal Spray) For The Treatment Of Perennial (Year-round) Allergic Rhinitis (NCT00609674)
Perennial Allergic Rhinitis: Once-Daily Investigational Nasal Spray In Adults And Adolescents With Perennial Allergic Rhinitis (PAR) (NCT00289198)
Peripheral Arterial Disease, Intermittent Claudication: Efficacy Study of Oral L-Citrulline in Patients Taking Simvastatin With Peripheral Arterial Disease (NCT00351286)
Peripheral Vascular Diseases: Efficacy and Safety of XRP0038/NV1FGF in Critical Limb Ischemia Patients With Skin Lesions (NCT00566657)
Peripheral Vascular Diseases, Intermittent Claudication: PROVIDENCE-1: Study of Rifalazil in Chlamydia Pneumoniae Seropositive Patients (NCT00251849)
Persistent or Permanent Non-valvular Atrial Fibrillation: Atrial Fibrillation (AF) Patients Not Taking Vitamin-K Antagonist (VKA) (NCT00623779)
Pneumonia: A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients (NCT00643227)
Pneumonia: A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients (NCT00643734)
Pneumonia: Study to Demonstrate the Clinical Efficacy of Levofloxacin in the Treatment of Pneumonia (NCT00253955)
Pneumonia: Venticute in Patients With Pneumonia or Aspiration of Gastric Contents and Intubation/Ventilation/Oxygenation Impairment (BY2001/M1-007) (NCT00074906)
Pneumonia, Community Acquired : Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia (NCT00640926)
Polycystic Kidney Disease: TEMPO 3/4 Trial Tolvaptan Efficacy and Safety in Management of Polycystic Kidney Disease and Its Outcomes (NCT00428948)
Post Acute Coronary Syndrome, Myocardial Ischemia: Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome (NCT00409578)
Post Cardiac Surgery Patients: Measurement of Cardiac Output and Blood Volumes Using Transonic Ultrasound Dilution Technology (NCT00756119)
Postmenopause: Endometrial Safety Study (NCT00522873)
Postmenopause: Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination (NCT00251082)
Postoperative Nausea and Vomiting: Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women (NCT00334152)
Postoperative Nausea and Vomiting: Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients (NCT00828295)
Prostate Cancer: A Phase III Trial of ZD4054 (Endothelin A Antagonist) in Hormone Resistant Prostate Cancer With Bone Metastases (NCT00554229)
Prostate Cancer: A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD (NCT00378690)
Prostate Cancer: An Extension Study Evaluating the Long-Term Safety and Tolerability of Degarelix One-Month Depots in Prostate Cancer (NCT00215683)
Prostate Cancer: An Open-Label, Multi-Centre, Extension Study (NCT00268892)
Prostate Cancer: Dose Finding Trial With a New Treatment (Degarelix) for Prostate Cancer (NCT00819156)
Prostate Cancer: Hormone Therapy in Treating Patients With Advanced Prostate Cancer (NCT00003026)
Prostate Cancer: Investigation of a New Trial Drug (FE200486) in Prostate Cancer Patients (NCT00818623)
Prostate Cancer: MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer (NCT00072930)
Prostate Cancer: REDUCE - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk (NCT00056407)
Prostate Cancer: Study of Irofulven in Patients With Hormone-refractory Prostate Cancer (NCT00124566)
Prostate Cancer: The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer (NCT00295750)
Prostate Cancer: ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases (NCT00294437)
Prostate Cancer After a Radical Treatment: ARTS - AVODART After Radical Therapy For Prostate Cancer Study (NCT00558363)
Prostate Cancer, Hormone Refractory Prostate Cancer, One Prior Cytotoxic Chemotherapy Regimen: Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen (NCT00069745)
Prostate Cancer, Metastatic: Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases (NCT00002503)
Prostate Cancer, Pancreatic Cancer, Non-Small-Cell Lung Cancer: Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate Cancer (NCT00312013)
Prostatic Neoplasms: Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy (NCT00283062)
Pseudomonas Aeruginosa, Cystic Fibrosis: Open Label Extension to Bridging Study CTBM100C2303 (NCT00982930)
Psoriasis: Dose Ranging Study of the Safety and Efficacy of R115966 in Plaque Psoriasis (NCT00716144)
Psoriatic Arthritis: A Placebo-Controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis (NCT00659412)
Puberty, Precocious: Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] (NCT00094328)
Puberty, Precocious, McCune-Albright Syndrome: Faslodex in McCune Albright Syndrome (NCT00278915)
Pulmonary Arterial Hypertension: A Long Term Extension Study Evaluating Safety of Sildenafil Citrate When Used to Treat Pulmonary Arterial Hypertension (PAH) in Children (NCT00159874)
Pulmonary Arterial Hypertension: Long-term Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension (NCT00667823)
Pulmonary Arterial Hypertension, Children: A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension. (NCT00159913)
Pulmonary Embolism, Thrombosis: Clinical Study Assessing SSR126517E Injections Once-weekly in Pulmonary Embolism Therapeutic Approach (NCT00345618)
Pulmonary Fibrosis: Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis (NCT00514683)
Pulmonary Hypertension: BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary Hypertension (NCT00910429)
Radius Fracture: A Phase IIa Study Of Men And Post-Menopausal Women With A Fractured Distal Radius (NCT00548496)
Relapsing Multiple Sclerosis: Atacicept in Multiple Sclerosis Extension Study, Phase II (NCT00853762)
Relapsing Multiple Sclerosis: Atacicept in Multiple Sclerosis, Phase II (NCT00642902)
Relapsing-Remitting Multiple Sclerosis: A Study for Patients With Relapsing Remitting Multiple Sclerosis (NCT00869986)
Relapsing-Remitting Multiple Sclerosis: Clarity Extension Study (NCT00641537)
Relapsing-Remitting Multiple Sclerosis: Rebif® Versus Copaxone® in the Treatment of Relapsing Remitting Multiple Sclerosis (NCT00078338)
Renal Cell Carcinoma, Advanced: Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer (NCT00387764)
Renal Carcinoma, Clear Cell: TroVax Renal Immunotherapy Survival Trial (NCT00397345)
Renal Cell Cancer: A Study of Avastin (Bevacizumab) Added to Interferon Alfa-2a (Roferon) Therapy in Patients With Metastatic Renal Cell Cancer With Nephrectomy (NCT00738530)
Renal Cell Carcinoma: A Phase III Study to Evaluate Safety and Efficacy of GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma (NCT00334282)
Renal Cell Carcinoma: A Study of Tivozanib (AV-951), an Oral VEGF Receptor Tyrosine Kinase Inhibitor, in the Treatment of Renal Cell Carcinoma (NCT00502307)
Renal Cell Carcinoma: ABR-217620 With Interferon-Alpha (IFN-Alpha) Compared to IFN-Alpha Alone in Patients With Advanced Renal Cell Carcinoma (NCT00420888)
Renal Cell Carcinoma: BAY 43-9006 (Sorafenib) Versus Interferon Alpha-2a in Patients With Unresectable and/or Metastatic Renal Cell Carcinoma (NCT00117637)
Renal Cell Carcinoma: Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens (NCT00591188)
Renal Cell Carcinoma: Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer (NCT00073307)
Renal Cell Carcinoma: SU011248 Versus Interferon-Alfa As First-Line Systemic Therapy For Patients With Metastatic Renal Cell Carcinoma (NCT00083889)
Renal Cell Carcinoma: Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma (NCT00130897)
Renal Disease, End-Stage: The Effect of Somatropin Treatment in Adult Patients on Chronic Dialysis (NCT00503698)
Renal Impairment, Diabetes: Pharmacokinetics of Vildagliptin in Mild, Moderate and Severe Renal Impaired Patients (NCT00818571)
Renal Insufficiency: Pharmacokinetics (PK) and Metabolism of FTY720 in Patients With Severe Renal Impairment and Healthy Matched Subjects. (NCT00731523)
Respiratory Syncytial Virus Infections: Study of MEDI-524 (Numax), for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children (NCT00129766)
Rheumatoid Arthritis: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to a Single Anti-TNF Inhibitor. (NCT00576433)
Rheumatoid Arthritis: A 6-month Randomised, Double-blind, Open Arm Comparator, Phase IIb, With AZD9056, in Patients With Rheumatoid Arthritis (NCT00520572)
Rheumatoid Arthritis: A Placebo Controlled Study to Assess Efficacy and Safety of Certolizumab Pegol in the Treatment of Rheumatoid Arthritis (NCT00152386)
Rheumatoid Arthritis: A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis (NCT00713544)
Rheumatoid Arthritis: A Safety and Tolerability Study of REGN88 in Subjects With Rheumatoid Arthritis (NCT01026519)
Rheumatoid Arthritis: A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis (NCT00134693)
Rheumatoid Arthritis: A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 (NCT00395577)
Patients With Active Rheumatoid Arthritis (NCT00160602)
Rheumatoid Arthritis: A Study of the Safety and Effectiveness of Lyophilized Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00175877)
Rheumatoid Arthritis: A Study of the Safety of Liquid Certolizumab Pegol in the Treatment of Signs and Symptoms of Rheumatoid Arthritis and in Prevention of Joint Damage in Patients With Active Rheumatoid Arthritis (NCT00160641)
Rheumatoid Arthritis: A Study to Assess the Effect of Tocilizumab + DMARD Therapy on Signs and Symptoms in Patients With Moderate to Severe Active Rheumatoid Arthritis (NCT00106574)
Rheumatoid Arthritis: A Study To Investigate The Effect Of 28 Days Of Dosing With GW856553 On Patients With Rheumatoid Arthritis (NCT00393146)
Rheumatoid Arthritis: Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis (NCT00095147)
Rheumatoid Arthritis: Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis (NCT00545454)
Rheumatoid Arthritis: An Extension Study of Tocilizumab in Patients Completing Treatment in Tocilizumab Core Studies (NCT00720798)
Rheumatoid Arthritis: Assessment Of The Safety And Efficacy Of BG9924 In Rheumatoid Arthritis (RA) Patients (NCT00664716)
Rheumatoid Arthritis: Assessment of the Safety and Efficacy of BG9924 in Rheumatoid Arthritis (RA) Patients (NCT00664573)
Rheumatoid Arthritis: BIIB023 (Anti-TWEAK) in Subjects With Rheumatoid Arthritis (NCT00771329)
Rheumatoid Arthritis: COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis (NCT00113308)
Rheumatoid Arthritis: Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis (NCT00554606)
Rheumatoid Arthritis: Multicenter Active RA Study (NCT00551707)
Rheumatoid Arthritis: Phase 2 Clinical Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702 (NCT00205478)
Rheumatoid Arthritis: Remission in Early Rheumatoid Arthritis (NCT00122382)
Rheumatoid Arthritis: Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis (NCT00504595)
Rheumatoid Arthritis: SCORE Study: A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate. (NCT00578305)
Rheumatoid Arthritis: Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients (NCT00686868)
Rheumatoid Arthritis : A Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid Arthritis (NCT00042068)
Rheumatoid Arthritis : An Oral p38 Inhibitor Investigating Safety, Efficacy, And PK In Subjects With Active Rheumatoid Arthritis (NCT00383188)
Rheumatoid Arthritis : Efficacy and Safety of TAK-783 in Subjects With Rheumatoid Arthritis (NCT00760968)
Rheumatoid Arthritis : Investigating Clinical Efficacy of Ofatumumab in Adult RA Patients Who Had an Inadequate Response to MTX Therapy (NCT00611455)
Rheumatoid Arthritis : Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis (NCT00867516)
Rheumatoid Arthritis : Study Comparing Etanercept in Combination With Methotrexate in Subjects With Rheumatoid Arthritis (NCT00565409)
Rheumatoid Arthritis, Juvenile : A One Year Double-blind Trial to Investigate the Efficacy and Safety of Meloxicam Oral Suspension in Juvenile Rheumatoid Arthritis (JRA/JIA) (NCT00279747)
Rheumatoid Arthritis, Juvenile : A Study to Evaluate the Efficacy and Safety of Celecoxib Suspension Compared to Naproxen Suspension in Patients With JRA (NCT00652925)
Schizophrenia: A Study for Patients With Schizophrenia (NCT00520923)
Schizophrenia: A Study of RO4917838 in Combination With Antipsychotic Treatment in Patients With Schizophrenia. (NCT00616798)
Schizophrenia: Aripiprazole for Schizophrenia Outpatients Completing BMS Clinical Trials (NCT00239356)
Schizophrenia: Aripiprazole Open-Label Rollover Study (NCT01001702)
Schizophrenia: Comparison of Intramuscular Olanzapine Depot With Placebo in the Treatment of Patients With Schizophrenia (NCT00088478)
Schizophrenia: Dose-response Study to Evaluate Safety, Efficacy, and Pharmacokinetics of PF-00217830 Compared With Placebo in Acute Exacerbation of Schizophrenia (NCT00580125)
Schizophrenia: Efficacy of Bifeprunox in Patients With Schizophrenia (NCT00658645)
Schizophrenia: Olanzapine Versus Placebo in the Treatment of Adolescents With Schizophrenia (NCT00051298)
Schizophrenia: Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Adolescent Patients With Schizophrenia (NCT00090324)
Schizophrenia: Safety and Efficacy of RGH-188 in the Acute Exacerbation of Schizophrenia (NCT00694707)
Schizophrenia: Safety and Efficacy of Ziprasidone in Adolescents With Schizophrenia (NCT00257192)
Schizophrenia: Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia (NCT00265382)
Schizophrenia: SB-773812 Administered In Adults With Schizophrenia (NCT00259870)
Schizophrenia: Study of LY2140023 in Schizophrenia (NCT00149292)
Schizophrenia: The Purpose of the Study is to Determine Whether Cariprazine is a Safe and Tolerated Long-term Treatment in Patients With Chronic Stable Schizophrenia (NCT00839852)
Schizophrenia, Bipolar Disorder: Olanzapine Treated Adolescents With Schizophrenia or Bipolar I Disorder (NCT00113594)
Schizophrenia, Bipolar I Disorder: Quetiapine Fumarate (SEROQUEL) in the Treatment of Adolescent Patients With Schizophrenia and Bipolar I Disorder (NCT00227305)
Schizophrenia, Psychotic Disorders: Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone (NCT00174200)
Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder: Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia (NCT00337662)
Schizophrenia, Schizoaffective Disorders: Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine (NCT00401973)
Schizophrenic Disorder: SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia (NCT00206115)
Schizophrenic Disorders: Comparison of the Subjective Well-Being and Tolerability of Quetiapine XR to Risperidone (NCT00600756)
Schizophrenic Disorders, Schizoaffective Disorder: Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder (NCT00088465)
Secondary Amyloidosis, Rheumatoid Arthritis, Nephrotic Syndrome, Familial Mediterranean Syndrome, Kidney Diseases, Gastrointestinal Diseases: Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis (NCT00035334)
Seizures, Tonic-Clonic, Epilepsy: Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Primary Generalized Tonic-Clonic Seizures (PGTC) Seizures (NCT00104416)
Sepsis: GR270773 In The Treatment Of Suspected Or Confirmed Gram-Negative Severe Sepsis In Adults (NCT00089986)
Sepsis: The Study of Drotrecogin Alfa (Activated) in a Subpopulation of Adult Patients With Severe Sepsis (NCT00045760)
Sinusitis: A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Sinus Infections in Adults (NCT00643409)
Skin Mycoses: Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses (NCT00722189)
Skin/Soft Tissue Infections, Methicillin Resistant Staphylococcus Aureus: Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA) (NCT00087490)
Sleep Initiation and Maintenance Disorders: Efficacy an Safety of Volinanserin on Sleep Maintenance Insomnia With a Sub-study on Stable Type II Diabetes Mellitus (NCT00464061)
Sleep Initiation and Maintenance Disorders: Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus (NCT00495885)
Sleep Initiation and Maintenance Disorders: Efficacy and Safety of Volinanserin on Sleep Maintenance Insomnia - Polysomnographic Study (NCT00464243)
Small Cell Lung Cancer: Study Of Irinotecan Hydrochloride (Campto(R)) And Cisplatin Versus Etoposide And Cisplatin In Small Cell Lung Cancer (NCT00143455)
Small Cell Lung Cancer: Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung Cancer (NCT00276276)
Small Cell Lung Cancer: Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology (NCT00596830)
Small Cell Lung Cancer: Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide (NCT00290953)
Small Cell Lung Cancer: Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults (NCT00043927)
Small Cell Lung Cancer: Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer (NCT00116610)
Small Cell Lung Cancer: Study of AT-101 in Combination With Topotecan in Relapsed/Refractory Small Cell Lung Cancer (NCT00397293)
Small Cell Lung Cancer: Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer (NCT00363415)
Small Cell Lung Cancer: Study of Picoplatin Efficacy After Relapse (NCT00465491)
Small Cell Lung Cancer, Non-Small-Cell Lung Cancer: Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC) (NCT00527735)
Social Anxiety Disorder: Safety of Escitalopram in Patients With Social Anxiety Disorder (NCT00902226)
Solid Malignancies, Advanced: Study of AZD8931 in Patients With Advanced Solid Malignancies (NCT00637039)
Squamous Cell Carcinoma of the Head and Neck: Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) (NCT00206219)
Chemoradiation in Locally Advanced Head and Neck Cancer (NCT00273546)
Squamous Cell Carcinoma of the Head and Neck, Advanced: Study of Proxinium Plus Best Supportive Care Versus Best Supportive Care for Patients With Advanced Head and Neck Cancer (NCT00412776)
Stomach Neoplasms: Docetaxel and Oxaliplatin in Gastric Cancer (NCT00382720)
Stroke, Acute, Neurological Impairment: A Study on the Use of Tanakan® for Recovery of Neurological Impairment Following Ischaemic Stroke (NCT00276380)
Stroke, Cerebral Ischemia, Brain Infarction: Ancrod (ViprinexTM) for the Treatment of Acute, Ischemic Stroke (NCT00141011)
Stroke, Cerebral Ischemia, Brain Infarction: ASP-II: Ancrod Stroke Program: Ancrod (ViprinexTM) for the Treatment of Acute, Ischemic Stroke (NCT00300196)
Superficial Thrombophlebitis: Evaluation Of Fondaparinux (Also Called ARIXTRA) 2.5 mg Subcutaneously Once Daily For The Treatment Of Superficial Thrombophlebitis (Also Known As Superficial Vein Thrombosis) (NCT00443053)
Systemic Lupus Erythematosus: A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 (NCT00712933)
Systemic Lupus Erythematosus: A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) (NCT00424476)
Thrombocytopenia: SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy (NCT00102726)
Thrombocytopenia, Hepatitis C: Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease (NCT00516321)
Thromboembolism: Efficacy and Safety of Dabigatran Compared to Warfarin for 6 Month Treatment of Acute Symptomatic Venous Thromboembolism (NCT00291330)
Thromboembolism: Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2) (NCT00353678)
Thrombosis, Hip Replacement: A Study of DU-176b in Preventing Blood Clots After Hip Replacement Surgery (NCT00398216)
Thyroid Cancer: An Efficacy Study Comparing ZD6474 to Placebo in Medullary Thyroid Cancer (NCT00410761)
Thyroid Cancer: Study of Irofulven Plus Capecitabine in Patients With Advanced Thyroid Cancer (NCT00124527)
Thyroid Nodules: Hemodynamic Parameters in Euthyroid Patients With Thyroid Nodules (NCT00507897)
Total Knee Replacement Surgery: Single Intravenous Administration of TB-402 for the Prophylaxis of Venous Thromboembolic Events (VTE) After Total Knee Replacement Surgery (NCT00793234)
Tuberculosis, Pulmonary: MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary Tuberculosis (NCT00495339)
Turner Syndrome, Renal Insufficiency, Chronic, Pituitary Diseases, Dwarfism: Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq (NCT00234533)
Ulcerative Colitis: A Double Blind Study for the Treatment of Acute Ulcerative Colitis (NCT00350415)
Ulcerative Colitis: A Phase 2 Study of Avonex in Ulcerative Colitis (NCT00616434)
Ulcerative Colitis: A Study of MDX-1100 in Subjects With Active Ulcerative Colitis (NCT00656890)
Ulcerative Colitis: A Study of the Safety and Effectiveness of CNTO 148 (Golimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (CR014188) (NCT00488774)
Ulcerative Colitis: Basiliximab in Moderate to Severe Ulcerative Colitis (NCT00430898)
Ulcerative Colitis: Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis (NCT00151892)
Ulcerative Colitis: Propionyl-L-Carnitine in Ulcerative Colitis (NCT01026857)
Ulcerative Colitis: Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis (NCT00299013)
Ulcerative Colitis: Study of Visilizumab in Subjects With Intravenous Steroid-Refractory Ulcerative Colitis (IVSR-UC) (NCT00307827)
Ulcerative Colitis, Inflammatory Bowel Disease: Nolpitantium Besylate In Patients With Ulcerative Colitis a Double-Blind, Placebo Controlled Efficacy and Safety Study (NCT00232258)
Unverricht-Lundborg Disease: Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease in Adolescents and Adults (NCT00368251)
Urinary Bladder, Overactive: Solifenacin Succinate 5mg or 10mg Once Daily in the Treatment of Urgency Symptoms (NCT00801944)
Urinary Bladder, Overactive: Solifenacin Succinate Versus Tolterodine 4mg Once Daily (NCT00802373)
Urinary Bladder, Overactive: Study to Test the Efficacy and Safety of the Beta-3 Agonist YM178 in Subjects With Symptoms of Overactive Bladder (NCT00689104)
Urinary Bladder, Overactive: Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist YM178 in Patients With Symptoms of Overactive Bladder (NCT00688688)
Uterine Myomas: PGL4001 Versus Placebo in Uterine Myomas (NCT00755755)
Vaginal Infection: Vaginal Infection Study 2 (NCT00694928)
Vascular Dementia: A Clinical Trial to Evaluate the Safety and Efficacy of 20 ml Cerebrolysin in Patients With Vascular Dementia (NCT00947531)
Vascular Dementia: Efficacy and Safety of Rivastigmine Capsules in Patients With Probable Vascular Dementia (NCT00099216)
Venous Thromboembolism: Dose Ranging Study in Elective Total Hip Replacement Surgery (NCT00338897)
Venous Thromboembolism: Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Elective Knee Replacement Surgery (NCT00718224)
Venous Thromboembolism: Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Hip Fracture Surgery (NCT00721760)
Venous Thromboembolism: Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery (NCT00697099)
Venous Thromboembolism: Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery (NCT00709904)
Venous Thromboembolism: Evaluation of AVE5026 in the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients With Restricted Mobility (NCT00714597)
Venous Thromboembolism: EXCLAIM:Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization (NCT00077753)
Venous Thromboembolism: Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery (TREK) (NCT00331838)
Venous Thromboembolism, Deep Vein Thrombosis, Pulmonary Embolism: Odiparcil For The Prevention Of Venous Thromboembolism (NCT00244725)
Venous Thrombosis: Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery (NCT00306254)
Vulvovaginitis, Vaginitis: Vaginal Infection Study (NCT00616330)
Source: http://clinicaltrials.gov/
More information: Clinical Trials Details
See also: Clinical Trials Approved by Roszdravnador
|
